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ABSTRACT 
REGULATION OF PROTEIN TURNOVER DURING HYPER-OSMOTIC STRESS IN 
SKELETAL MUSCLE 
Cody Vandommele        
 Advisor Brock University        
 Dr. B.D. Roy 
 
The purpose of this study was to examine the effect of hyper-osmotic stress on 
protein turnover in skeletal muscle tissue using an established in-vitro model. Rat 
EDL muscles were incubated in either hyper-osmotic (400 ± 10 Osm) or iso-
osmotic (290 ± 10 Osm) custom-modified media (Gibco). L-[14C]-U-phenylalanine 
(n=8) and cycloheximide (n=8) were used to quantify protein synthesis and 
degradation, respectively. Western blotting analyses was performed to determine 
the activation of protein synthesis and degradation pathways. During hyper-
osmotic stress, protein degradation increased (p<0.05), while protein synthesis 
was decreased (p<0.05) as compared to the iso-osmotic condition. The decline in 
protein synthesis was accompanied by a decrease (p<0.05) in p70s6 kinase 
phosphorylation, while the increase in protein degradation was associated with 
an increase (p<0.05) in autolyzed calpain. Therefore, hyper-osmotic extracellular 
stress results in an intracellular catabolic environment in mammalian skeletal 
muscle tissue. 
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CHAPTER 1.1: WATER – THE CELLULAR BASIS OF LIFE 
I. Introduction 
Water is the one of the most important molecules in the human body, 
where it accounts for approximately 55-60% of total body weight (Macknight and 
Leaf 1977). It is vital for a variety of functions that are critical to survival such as 
the regulation of pH and body temperature. Water is also involved in the delivery 
of O2/nutrients to cells throughout the body, as it is a large component of blood. 
Blood plasma consists of approximately 90% water, with the other 10% made up 
of dissolved proteins, clotting factors, glucose, hormones, mineral ions and CO2. 
Another key function of water is the ability to act as a solvent. Sugars, salts, 
amino acids, minerals and an array of other nutrients/molecules are dissolved in 
water, which provides an optimal medium for cellular reactions to occur. The 
solvent properties of water can also lead to trans-membrane fluid shifts between 
tissues and cells of the body (See Osmolality section). As noted by the examples 
above, it is clear that adequate hydration is necessary for the maintenance of 
homeostasis and optimal bodily function.  
II. Compartmentalization of Fluids 
Water is not evenly distributed throughout the body, as it is separated into 
intracellular and extracellular compartments. Intracellular water is comprised of 
all water that is located within the cells of the body and accounts for 2/3 of total 
body water. It provides the base for the cytoplasm, which in turn, provides the 
medium for metabolic reactions and other cellular processes to occur. 
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Extracellular water is all water that is not located within the cells of the body. It 
accounts for the remaining 1/3 of total body water. The extracellular compartment 
can be further sub-divided into the plasma, interstitial and lymphatic 
compartments. Plasma is the liquid component of blood and consists of 
approximately 90% water. Interstitial fluid is the fluid that surrounds the cells of 
the body. It provides a means for delivering nutrients from the bloodstream to the 
cell as well as removing any waste that is released by the cell and returning it to 
the vasculature. Interstitial fluid may also have a protective role for certain cells in 
the body (e.g. brain cells) as the fluid cushions the cell during forceful impacts. 
The lymphatic system makes up the final part of the extracellular compartment, 
and is defined as a collection of ducts, tissues, and nodes that are spread 
throughout the body and carry lymph within them. Lymph is similar to blood 
plasma in composition but also contains white blood cells. While the lymphatic 
system has multiple functions, its main function in terms of water balance is to 
return excess interstitial fluid to the blood (Swartz and Boardman 2002). Excess 
interstitial fluid can lead to trans-membrane fluid shifts and subsequent cell 
volume changes, which can affect cellular processes therefore the lymphatic 
system is also vital for water balance.    
III. Osmolality  
Osmolality and osmolarity are two terms that are often used 
interchangeably but are unique measures. Osmolarity is the amount of dissolved 
solute in a solution. Since it is relative to the amount of solution, it is measured in 
osmoles per litre (Osm/L). Osmolality, on the other hand, is the amount of solute 
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dissolved per kilogram of solvent (Osm/kg). The volume of a solution will change 
with the addition of solutes or with changes in temperature and pressure, thereby 
influencing osmolarity. The weight of solvent remains the same regardless of 
temperature, pressure, or solutes added; therefore osmolality is a more constant 
measure.  
In the body, normal serum osmolality varies between 285-295 mmol/kg of 
water, but environmental stressors (e.g. exercise, diet, hydration, diabetes) can 
lead to altered extracellular osmolalities which subsequently lead to trans-cellular 
fluid shifts (Kraft 2000). There are three different physiological extracellular 
osmotic states that can influence intracellular volume. A hypotonic extracellular 
osmotic environment (<285mmol/kg) occurs when there are a fewer number of 
solutes in the extracellular space than are located within the cytoplasm. To 
equilibrate this osmotic gradient, water is rushed into the cell resulting in a net 
increase in cell volume. A hypertonic extracellular osmotic environment 
(>295mmol/kg) occurs when there are a greater number of solutes in the 
extracellular media than within the cytoplasm. Ultimately, water leaves the cell 
and cell volume decreases. Finally, an iso-osmotic extracellular environment 
occurs when there are an equal amount of solutes in the cytoplasm and 
extracellular space therefore an equal amount of water enters and exits the cell 
leaving cell volume constant. This is the favoured osmotic state of the cell. It 
appears that cell volume is well controlled, and that cells possess homeostatic 
mechanisms which attempt to maintain cell volume at a preferred cell size 
(Okada 2004) (See Cell Volume Regulation Section).  
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VI. Water Transport	  	  
It was initially believed that water moved between body compartments 
only by way of simple diffusion.  Extensive research on an assortment of tissues 
has established that different tissues have varying water permeabilities (Nielsen, 
Chou et al. 1995; Koyama, Yamamoto et al. 1997). These findings lead 
researchers to investigate the existence of other possible water pathways. It is 
now known that there are three routes of trans-membrane water movement: 
simple diffusion, co-transport, and aquaporins (Borgnia, Nielsen et al. 1999).  
Simple diffusion is the passing of a substance from an area of high 
concentration to an area of low concentration through a membrane without the 
aid of a membrane protein. Water passes through the hydrophobic phospholipid 
bi-layer but is highly dependent on the presence of a large concentration 
gradient. Since it is a passive process and the membrane is partially 
hydrophobic, the process is relatively slow.  
The second method of water movement is that of co-transport. This occurs 
when water is moved across a cell membrane with other molecules.  Different 
molecules and ions possess varying osmotic effects; therefore water will tend to 
follow certain ions and molecules more than others as they are passed through a 
membrane. An example of this involves the NKCC co-transporter. This symporter 
is responsible for moving Na+, K+, and two Cl- ions across the membrane in 
addition to water (Gosmanov, Lindinger et al. 2003). Co-transport is an effective 
method for mass water transport but is dependent on other cellular processes. 
These symporters are not specific to water therefore co-transport is dependent 
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on the ion concentrations inside and outside of the cell. It is the ion flux which is 
regulated in this instance, not the water concentration.  
The final pathway for water transport is through aquaporin channels. 
Aquaporins were first discovered in the late 1980’s by accident when researchers 
were attempting to identify Rh blood group antigens (Agre, Saboori et al. 1987). 
The protein fragment was  analyzed and purified over the next few years and 
eventually determined to have channel-like properties that were specific to water 
(Smith and Agre 1991). Researchers confirmed these findings using oocytes 
expressing the newly found protein. The oocytes were placed into a hypotonic 
solution where they swelled until exploding. It was later found that their 
coefficient of osmotic water permeability was 20 times that of control oocytes 
(See Figure 1) (Preston, Carroll et al. 1992). This marked the discovery of the 
water channel and the term aquaporin was coined (Agre, Sasaki et al. 1993). 
Aquaporins have since been found in plants, animals and microorganisms. To 
date, there have been 13 different aquaporin proteins identified in the human 
body. The two main classifications of in the body are: aquaporin and 
aquaglyceroporin. Aquaporin 1, 2, 4, 5, and 8 only allow water to flow through 
them, while aquaglyceroporin 3, 7, 9, and 10 move water in addition to other 
small solutes such as glycerol and urea (Verkman 2005). It is estimated that 3 X 
109 water molecules pass through a given aquaporin channel in one second, 
which makes them the primary source of water transport in the body (Zeidel, 
Ambudkar et al. 1992). In humans, these water channels can be found in a 
variety of tissues including: brain, skeletal muscle (which has primarily AQP-4), 
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liver, but most notably in the kidney. Aquaporin 1, 2, 3, 4, 6, 7, and 8 can all be 
found in various parts of the kidney, primarily within the nephron. While 
aquaporin throughout the body vary slightly in terms of function, they work 
collectively to maintain body water balance (Nielsen, Frokiaer et al. 2002).  
 
                 
 
 
FIGURE 1. The discovery of aquaporins in Xenopus laevis oocytes. Cells were 
injected with AQP1 RNA and placed in a hypo-osmotic environment where cell 
swelling occurred (Preston, Carroll et al. 1992) 
 
V. Whole Body Hydration and Fluid Shifts	  
Whole body water balance is largely regulated through the endocrine 
system. The main endocrine hormones involved include: anti-diuretic hormone 
(ADH), angiotensin II and atrial natriuretic peptide (ANP). ADH is a peptide 
hormone that is released from the posterior pituitary gland and acts primarily on 
the kidneys. Upon an increase in plasma osmolality, osmoreceptors in the 
hypothalamus signal to the pituitary gland to release ADH into the bloodstream. 
Once reaching the kidneys, ADH increases the permeability of the collecting duct 
in the nephron to allow increased reabsorption of water (Bonjour and Malvin 
1970). This action helps to restore iso-osmotic conditions in the plasma. During 
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conditions of hypo-osmotic plasma, ADH secretion by the posterior pituitary 
gland is suppressed.   
Angiotensin II and ANP also play a large role in whole body water 
regulation. When blood volume is low (e.g. dehydration), the kidney secretes 
renin into circulation. Renin will travel in the bloodstream until it reaches the liver 
where it then facilitates the conversion of angiotensinogen into angiotensin I. 
Angiotensin I is released by the liver into circulation and is subsequently 
converted into angiotensin II by angiotensin converting enzyme, which can be 
found in the lungs. Upon its activation, angiotensin II acts on blood vessels, 
causing vasoconstriction, and thereby increasing blood pressure. In terms of 
water balance, angiotensin II also stimulates an increase in the release of the 
hormone aldosterone. Aldosterone causes Na+ ions and H2O to be reabsorbed 
from the distal convoluted tubule and collecting duct of the nephron into 
circulation. This action helps to restore whole body hydration levels. ANP is also 
involved in whole body water balance. Once iso-osmotic conditions are achieved 
in plasma, ANP is released into circulation by the heart. ANP acts to suppress 
the release of renin and aldosterone (Antunes-Rodrigues, de Castro et al. 2004). 
Together, ADH, angiotensin II and ANP work to regulate water intake and 
excretion. 
Fluid shifts between the plasma and interstitium are affected by two 
forces: hydrostatic and colloid osmotic forces. Hydrostatic pressure is the 
pressure generated by fluid pushing against the walls of the blood vessels (Reed 
1981). This results in fluid being forced out of the blood vessels and into the 
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interstitium. Colloid osmotic pressure is the force that draws fluid from the 
interstitium back into the vasculature. It is primarily due to the osmotic effect of 
blood proteins. These proteins are too large to leave the capillaries but possess 
an osmotic effect that helps to draw water into the capillaries. Together, 
hydrostatic pressure and colloid osmotic pressure provide a balance of forces 
that equilibrates fluid between the capillaries and the interstitium.  
Similar to the rest of the body, fluid shifts are constantly occurring between 
intracellular and extracellular water compartments. Generally, variations in 
extracellular osmotic environment are responsible for trans-membrane fluid 
shifts. These environments can be the result of a variety of stimuli such as 
physical exercise, diet, hormones and injury/disease. In conditions of cell 
shrinkage (e.g. exercise, dehydration) it is suggested that fluid shifts serve to 
protect cardiovascular function first and foremost, as maintenance of blood 
volume is critical for regulation of arterial blood pressure and thermoregulation 
(Fortney, Nadel et al. 1981). During exercise, blood volume is initially decreased 
as fluid is released through pores of the skin as sweat. Although sweat 
production provides a thermoregulatory role for the body, cardiac output and 
stroke volume are decreased which diminishes endurance exercise capacity 
(Fortney, Wenger et al. 1983). Optimal blood transport cannot be sustained with 
these declines in plasma therefore blood volume must be replenished. In the 
long-term, water becomes redistributed within its compartments to return blood 
plasma to an adequate fluid level. This restoration of plasma occurs with or 
without fluid replacement as the increasing osmolality of blood plasma (due to 
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fluid loss from sweat and increased concentration of Na+) creates an osmotic 
gradient that draws water to the vasculature (Sanders, Noakes et al. 2001). 
Water follows an osmotic gradient from the intracellular compartment to the 
interstitium to the blood plasma. As fluid loss worsens, there is a 
disproportionately greater water loss from the intracellular compartment in order 
to maintain blood volume (See Figure 2) (Costill, Cote et al. 1976; Durkot, 
Martinez et al. 1986) 
      
 
FIGURE 2.  Water loss from bodily compartments during dehydration. As the 
body dehydrates, total body water lost is increased. As dehydration worsens, a 
higher % of water is lost from the intracellular compartment. Adapted from 
Costille, Cote et al. 1976; Durkot, Martinez et al. 1986. 
0	  
0.5	  
1	  
1.5	  
2	  
2.5	  
3	  
3.5	  
4	  
-­‐2.2	  
To
ta
l	  B
od
y	  
W
at
er
	  L
os
s	  
(L
)	  
Level	  of	  Dehydra�on	  (%)	  
Plasma	  
Inters��al	  
Intracellular	  
-­‐4.1	   -­‐5.8	  
30%	  
60%	  
10%	  
52%	  
10%	  
38%	  
50%	  
39%	  
11%	  
30%	  
10	  
	  
CHAPTER 1.2: CELL VOLUME DETECTION AND REGULATION 
I. Cell Volume Detection 
There is no consensus as to how cells detect changes in cell volume. 
However, two different theories have been proposed: mechanically-induced and 
osmotically-induced cell volume detection.  
Ia. Mechanical Cell Volume Detection	  
Mechanically induced cell volume detection has been suggested to occur 
as the result of deformation of the cell membrane due to extracellular osmotic 
stress (Parker 1993). In this theory, the cell membrane experiences either 
stretching (cell swelling) or bending (cell shrinkage) and results in a re-
arrangement of the cytoskeleton within the cell. These perturbations result in 
intracellular signals being transmitted through the cell which activate 
mechanisms to attempt to return the cell to its preferred cell volume. In terms of 
water transport specifically, it is hypothesized that aquaporin and ion channels 
are recruited to the membrane (similar to GLUT-4 translocation) in order to move 
water (Sachs 1991).  
Research in red blood cells (RBC’s) has generated uncertainty around the 
theory of mechanical cell volume detection. RBC’s have been shown to swell to 
1.6 times their normal cell volume without experiencing any cell membrane 
stretch. This is attributed to their biconcave shape. However, KCl channels, 
which are known to be a main mechanism of water efflux following cell swelling, 
were shown to become activated well before RBC’s experienced membrane 
stretch (Jennings and Schulz 1990). These findings contradict the theory of 
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mechanical cell volume detection. The theory was further tested by researchers 
using ghost cells (resealed RBC’s with the same cytoplasmic protein 
concentration and surface area but a smaller cell volume) and control RBC’s. 
The researchers compared the two cell types in regulatory volume changes (KCl 
activation) and observed that both cell types underwent KCl channel activation 
upon changes in intracellular osmolality, whereas the difference in cell volume 
did not have an effect (Colclasure and Parker 1992). Although these findings 
oppose the theory of mechanical cell volume detection, results from RBC’s may 
not translate to other cell types, therefore further research is warranted.     
Ib. Osmotic Cell Volume Detection	  
Osmotically induced cell volume detection occurs when impermeable 
components of the cell (i.e. proteins, carbohydrates, lipids, and nucleic acids) 
change in concentration due to the alterations in fluid content, which is then 
detected by the cell (Sarkadi and Parker 1991). It is hypothesized that these 
concentration changes will trigger intracellular signalling pathways and 
mechanisms to return the cell to its normal cell volume (Sarkadi and Parker 
1991). This theory is in accordance with the theory of macromolecular crowding; 
the crowding that occurs within the cell due to the large presence of 
macromolecules within the cytoplasm. Macromolecular crowding has been 
shown to affect the properties of macromolecules and enzymes which 
subsequently influence chemical processes (e.g. protein transcription) within the 
cell (Zimmerman 1993; Garner and Burg 1994).  
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II. Cell Volume Regulation	  	  
Many systems in the human body are homeostatically regulated and cell 
volume is no different. It has been established that cell volume is dynamic but in 
order to maintain optimal function, the cell will	  attempt to maintain a stable 
volume. In addition, evidence suggests that cell volume can act as a signal within 
the cell (see Cell Volume and Metabolism section) therefore cell volume must be 
tightly controlled. To achieve this, there are mechanisms in place which attempt 
to return the cell to its original cell volume. These general mechanisms are 
known as Regulatory Volume Decrease (RVD) and Regulatory Volume Increase 
(RVI). When a cell is placed in a hypo-osmotic solution the cell will initially swell 
and RVD mechanisms are then engaged. When a cell is placed in a hyper-
osmotic solution the cell will initially shrink followed by activation of RVI 
processes. Both mechanisms are acute and represent rapid attempts to return 
cell volume to a homeostatic level. Since cell shrinkage is the focus of the current 
study, I will concentrate solely on RVI mechanisms. 
IIa. Regulatory Volume Increase	   
No single mechanism is responsible for water influx into the cell following 
cell shrinkage but instead a variety of channels, transporters and molecules are 
used. The major mechanisms include:  the Na+/H+ exchange port (NHE), Na+-K+-
2 Cl- co-transporter (NKCC1) and organic osmolytes. Upon cell shrinkage, it is 
speculated that NHE’s are activated to allow Na+ to enter the cell while H+ is 
extruded. The proposed mechanism is a decrease in cell volume will increase the 
affinity of an allosteric site on NHE for intracellular H+, which in turn will activate 
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the exchanger (Grinstein, Rothstein et al. 1985). The NKCC is similarly reliant on 
Na+ to initiate water influx. This transporter is responsible for transporting one 
Na+, one K+, and two Cl- ions into the cell. This action helps to increase 
intracellular osmolality and promote the flow of water into the cell (Haas and 
Forbush 1998). The activation of this transporter is believed to be due to 
phosphorylation of the transporter during hyper-osmotic induced cell shrinkage 
(Gagnon, England et al. 2007).  
During RVI, elevated concentrations of intracellular ions have the potential 
to negatively influence cell function (e.g. fluctuation of pH, function of proteins, 
denaturation of macromolecules, alteration of resting membrane potential) 
(McManus, Churchwell et al. 1995). Organic osmolytes provide an alternative 
route of cell volume maintenance that is less stressful to the cell as ion flux is not 
involved. Osmolytes are organic compounds that can either be taken up by or 
synthesized within the cell and function to increase intracellular osmolality. As 
osmolytes accumulate, intracellular ions can be released without sacrificing cell 
volume. There are three main classes of organic osmolytes: polyols (sorbitol, 
myoinositol and inositol), methylamines (betaine, glycerophosphorylcholine), and 
amino acids (taurine, glutamine, glutamate, glycine and aspartate) (Lang, Busch 
et al. 1998). Different cell types make use of different osmolytes. Due to the 
adverse long-term effects of ion entry, ion flux is generally seen as an acute 
mechanism of RVI, whereas organic osmolyte accumulation provides a more 
long-term solution to cell volume (Lang, Busch et al. 1998).    
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 Cell volume regulation is an extremely complex process with multiple 
mechanisms involved. It is important to note that different cell types will regulate 
cell volume differently. In order to maintain optimal function, cell volume must be 
tightly controlled as cell volume fluctuations have been shown to influence 
intracellular reactions within the cell, particularly metabolic reactions (see Cell 
Volume and Metabolism section). 
III. Cell Volume and Metabolism	  
Extensive research on hepatocytes in the early 1990’s has shown that 
cellular hydration influences metabolic pathways within the cell (Haussinger, 
Lang et al. 1994). This research led to the development of the cell swelling 
theory, which states that cellular volume acts as a signal and has control over 
metabolic pathways within the cell. More specifically, cellular swelling creates an 
anabolic environment, while cellular shrinkage promotes an intracellular catabolic 
environment. The reason for these metabolic alterations are unknown but have 
been hypothesized to serve as a form of osmoregulation. During cell swelling, the 
synthesis of macromolecules reduces the osmotic effect of smaller organic 
molecules thereby limiting water influx. The opposite is true for cell shrinkage; the 
degradation of macromolecules into smaller organic molecules increases the 
overall osmotic effect and promotes the uptake of water. The remainder of this 
thesis will focus on cell shrinkage.  
Metabolic pathways and intracellular metabolites (ATP, PCr) have been 
shown to be affected by hyper-osmotic induced cellular shrinkage in a variety of 
tissues (Haussinger 1996; Antolic, Harrison et al. 2007). Within carbohydrate 
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metabolism, cell shrinkage has been shown to inhibit glycogen synthesis as well 
as stimulate glycogen breakdown (Graf, Haddad et al. 1988; Baquet, Hue et al. 
1990). There has been little research dedicated to hyper-osmotic induced cell 
shrinkage and fat metabolism. However, protein turnover and hyper-osmotic 
stress has received a great deal of attention in the academic community. In 
hepatocytes, hyper-osmotic induced cell shrinkage has been shown to suppress 
protein synthesis while stimulating protein degradation (See Figure 3) (Stoll, 
Gerok et al. 1992). Researchers have confirmed these findings on a whole body 
level (Berneis, Ninnis et al. 1999). 
Cellular hydration has been shown to influence metabolic pathways and 
processes within the cell as noted by the examples above. Of particular interest 
is the suppression of protein synthesis and stimulation of protein degradation 
during cell shrinkage. The majority of research in the area has been conducted 
using hepatocyte models but applications in skeletal muscle could be significant 
due to its large source of functional protein. 
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FIGURE 3. Cell shrinkage and protein turnover in hepatocytes. Cell shrinkage 
creates an intracellular catabolic environment and negative net protein balance 
(Stoll, Gerok et al. 1992) 
	  
CHAPTER 1.3: SKELETAL MUSCLE AND PROTEIN METABOLISM   
The ability to contract and produce force makes skeletal muscle cells one 
of the more unique cell types within the body. To support this property, skeletal 
muscle contains a large store of myofibrillar protein. The two major proteins in 
muscle, actin and myosin, interact to develop force through the cycling of cross-
bridges. Several other proteins serve to stabilize the structure of the sarcomere 
(e.g. desmin, titin). Intracellular proteins are continually synthesized and 
degraded in order to maintain optimal muscle function. To support this 
regeneration, skeletal muscle contains the largest store of amino acids in the 
body (Bergstrom, Furst et al. 1974). Factors such as muscular damage, amino 
acid availability, disuse, cachexia, and disease have the ability to influence rates 
of protein synthesis and degradation (Rennie 1985; Garibotto, Russo et al. 1994; 
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Cooney, Kimball et al. 1997; Phillips, Glover et al. 2009). Overall, skeletal muscle 
contributes approximately 25–30% of whole body protein turnover (Balagopal, 
Rooyackers et al. 1997). 
Protein turnover involves two major mechanisms: protein synthesis and 
protein degradation. Protein synthesis is the building of proteins and can be 
further broken down into transcription and translation processes. Transcription is 
the process of creating a complementary RNA copy from a specific DNA 
sequence. Translation involves the recruitment of specific amino acids that 
correspond to the transcribed mRNA molecule, followed by construction of the 
protein at the level of the ribosomes. Conversely, protein degradation is the 
digestion of proteins into amino acids. Proteins can be used as a nutritional 
source but often it is older or damaged proteins that are targeted. Several 
mechanisms can be used within muscle to degrade protein including: the 
ubiquitin proteasome system and calpain system (See Protein Degradation 
Section). 
Skeletal muscle houses a large store of both functional protein and amino 
acids. In addition, protein turnover in skeletal muscle is dynamic and can be 
influenced by a variety of factors. For these reasons, skeletal muscle is an 
attractive tissue to investigate in terms of protein turnover.  
I.	  Fluid Shifts in Skeletal Muscle	  
Although a number of factors can influence cellular hydration in skeletal 
muscle, physical exercise is one of the main triggers. During exercise, significant 
fluid shifts are seen between the vasculature, interstitium and intracellular 
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(muscle cell) compartments. In order to supply the working muscles with O2 and 
nutrients, an increase in cardiac output is required, which in turn, increases blood 
pressure. This results in an increase in hydrostatic pressure, which consequently, 
forces fluid out of the capillaries and into the interstitial space (El-Sayed 1998). In 
addition to these events, increased energy turnover within the muscle leads to a 
build-up of metabolic by-products, thereby increasing intracellular osmolality 
(Lindinger, Spriet et al. 1994). Altogether, these actions result in the net 
movement of water from the capillaries into the active muscle cells, resulting in 
an acute increase in muscle cell volume. However, during prolonged exercise, 
plasma volume is decreased due to sweating. This results in a net decrease of 
both total body fluid and muscle cell volume. Similar to other cell types, there is a 
disproportionately greater water loss from the intracellular compartment in order 
to maintain blood volume during prolonged exercise (See Figure 2) (Costill, Cote 
et al. 1976; Durkot, Martinez et al. 1986). 
Aside from exercise, other conditions (e.g. diabetes) can lead to skeletal 
muscle fluid shifts. The signature characteristic of diabetes is hyperglycaemia 
due to insulin unresponsiveness or deficiency. The chronic elevation of blood 
glucose can have adverse effects on organs throughout the body including the 
eyes, kidneys, and blood vessels. To counteract, the body will attempt to reduce 
plasma blood glucose by excreting glucose through urine. As a result, total body 
water is reduced and dehydration can occur. In addition, long-term diabetes 
(Type I and II) has been shown to result in increased vascular permeability to 
both small and large proteins in skeletal muscle (Trap-Jensen 1970; Parving and 
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Rossing 1973; Leinonen, Matikainen et al. 1982). As a result, proteins move from 
the vasculature to the interstitium, thereby increasing interstitial osmolality. To 
equilibrate, fluid is drawn from within the muscle cell resulting in muscle cell 
shrinkage (Fauchald, Norseth et al. 1985).  
II. Cell Volume and Skeletal Muscle Metabolism	  
According to the theory of cell swelling, cell volume acts as a signal and 
has influence over metabolic pathways within the cell. Over the past decade, 
research has begun to elucidate this theory in skeletal muscle. Through an 
isolated muscle model, researchers have demonstrated the effect of extracellular 
osmolality on skeletal muscle cell volume as well as the responsiveness of 
muscle fiber types to fluid shifts (Antolic, Harrison et al. 2007). Furthermore, 
researchers have investigated the influence of extracellular hyper-osmotic stress 
on glucose uptake as well as recovery of glucose kinetics from hyper-osmotic 
stress. Glucose uptake was found to increase in isolated intact EDL muscles 
after they being exposed to extracellular hyper-osmotic stress for 60 minutes; this 
increase could be reversed by exposing the same muscle to iso-osmotic 
extracellular media for 5 minutes (Farlinger 2007; Mulligan 2008). Despite 
evidence of skeletal muscle as a large storage site for amino acids and functional 
protein, as well as a tissue which faces osmotic challenges in a variety of 
conditions (e.g. exercise and diabetes), little research has been dedicated to the 
cell shrinkage and protein turnover in skeletal muscle, until recently when 
researchers quantified total protein synthesis under osmotic stress (Roy 2009). 
Using a cell culture model, L-6 muscle cells were placed in hyper-osmotic and 
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hypo-osmotic solutions and protein synthesis was subsequently measured. A 
hyper-osmotic environment was found to suppress protein synthesis while no 
changes were seen in a hypo-osmotic environment (See Figure 4). This 
decrease in protein synthesis was attributed to the suspected catabolic state of 
the cell. While this study was extremely novel in its findings, further research is 
necessary to understand the bigger picture. Total protein degradation was not 
measured in the experiment which results in an incomplete picture of protein 
turnover. Secondly, although the cell culture model used provides a certain level 
of control within an experiment, it is not very physiological. An isolated intact 
skeletal muscle would provide a more physiological model as the structure of the 
muscle is completely intact and viable. Lastly, measuring the activity of specific 
protein anabolic and catabolic pathways would allow for a more in-depth 
understanding of the effect of extracellular hyper-osmotic stress on protein 
turnover in skeletal muscle.  
 
 
       
     
21	  
	  
          
 
FIGURE 4. Protein synthesis during hyper-osmotic stress in skeletal muscle cell 
culture. L-6 muscle cells were placed under hypo-osmotic, hyper-osmotic or iso-
osmotic conditions for either 24 or 48 hours. Hyper-osmotic stress was shown to 
suppress total protein synthesis at both time points. Hypo-osmotic conditions had 
no effect on protein synthesis (Roy 2009).   
 
III. Protein Degradation Pathways  
IIIa. Ubiquitin Proteasome System  
The ubiquitin proteasome pathway is one of the main systems of protein 
degradation in skeletal muscle. It is a multi-unit complex known as the 26S 
proteasome, which is comprised of three subunits: a core 20S unit and two 19S 
subunits (Pickart and Cohen 2004). In this model, proteins become tagged for 
degradation by linking ubiquitin to targeted proteins. The complex also consists 
of three enzymes: E1, E2, and E3. There are three main steps in the ubiquitin 
proteasome pathway; the first step involves E1, which is an ATP-dependent 
enzyme that activates ubiquitin by forming a thiol ester bond between the E1 
enzyme and ubiquitin (See Figure 5). This prepares the proteasome for protein 
degradation as only proteins tagged with ubiquitin can be degraded. The second 
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step involves the transfer of activated ubiquitin from E1 to a specific cysteine 
residue on E2 via another thiol ester bond. E2 also adds the first ubiquitin to the 
targeted protein. There are several E2 enzymes in the proteasome complex that 
can perform this function. The third step occurs when activated ubiquitin is 
transferred from E2 enzymes to a cysteine residue located on the E3 enzyme 
(Hershko and Ciechanover 1992). Once attached, E3 enzymes continue to add 
multiple ubiquitin molecules to the targeted protein (poly-ubiquitination). The 
protein cannot be degraded until at least four or more ubiquitin molecules have 
been added the protein (Pickart 2000). At this point, the 26S proteasome will 
degrade the targeted protein into polypeptides molecules. Ubiquitin molecules 
are released from the poly-ubiquitin chain once the targeted protein has been 
degraded and the ubiquitin molecules can be subsequently recycled and used in 
the degradation of other proteins.  
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FIGURE 5. The ubiquitin proteasome system. Figure adapted from 
http://www.cellsignal.com/reference/pathway/Ubiquitin_Proteasome.html. E1 
enzyme activates ubiquitin by binding to it. E2 attaches the 1st ubiquitin to protein 
of interest. E3 adds further ubiquitin molecules. 26S proteasome degrades 
proteins into poly-peptide chains.  
 
During skeletal muscle atrophy, the E1, E2 and E3 enzymes have been 
shown to experience a change in expression, specifically E3 or ubiquitin ligases. 
Several E3 ligases have been identified in a variety of cell types, but two appear 
to be more important in skeletal muscle atrophy: MuRF1 and Atrogin-1. Using 
immobilization and hind-limb suspension models in rodents, researchers found 
an up-regulation of the Atrogin-1 gene in all cases. As a follow-up, an Atrogin-1 
KO model was subjected to muscle denervation and it was found atrophy was 
attenuated by 56% at 14 days (Bodine, Latres et al. 2001). In the same study, 
MuRF1 was also identified as an E3 ligase which was up-regulated in all models 
of skeletal muscle atrophy. These results were later confirmed using a muscle 
unloading model (Stevenson, Giresi et al. 2003). The effects of these scientific 
models, specifically hind-limb suspension, may be mediated by cellular 
dehydration, due to the effects they have on skeletal muscle fluid balance. 
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Researchers have consistently shown that the hind-limb suspension model 
results in a decrease of intracellular water content in skeletal muscle (Booth 
1982; Aoki, Lima et al. 2004). This is partly due a reduction in muscle cell 
diameter but with this comes a decrease in intracellular water. Additionally, 
researchers have shown an increase of AQP 4 protein expression in skeletal 
muscle during hind-limb suspension (Basco, Nicchia et al. 2010). This increase is 
believed to be linked to the efflux of water from within the cell. Although hind-limb 
suspension does not directly represent cellular shrinkage, the model does 
represent a loss of intracellular water.  
    Another environment where muscle cell shrinkage and increased 
protein degradation are present is space flight (micro-gravity). On Earth, most 
body water is located in the lower extremities due to gravitational pull. Upon 
entering micro-gravity conditions, water becomes redistributed within the body 
resulting in a head-ward shift of fluid and a subsequent decrease in muscle cell 
volume in the lower half of the body (Moore and Thornton 1987). In addition to 
fluid redistribution, space flight has been shown to result in an up-regulation of 
the ubiquitin proteasome system. Rodents were shuttled into space and exposed 
to micro-gravity for 2 hours before euthanasia. Lower limb muscles were excised 
and western and northern blotting analyses was performed. Researchers found 
an increase in ubiquitin mRNA as well as ubiquitinated protein. In addition, RC2 
and RC9, subunits of the proteasome, were found to have an increased 
expression (Ikemoto, Nikawa et al. 2001). The cause of the up-regulation of the 
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proteasome remains unclear, but it is possible that skeletal muscle cell hydration 
may be contributing to the regulation of this system.  
  The ubiquitin proteasome pathway is one of the major pathways for 
protein degradation within skeletal muscle. Certain scientific models (e.g. hind-
limb suspension, micro-gravity) which result in cell volume shrinkage have shown 
an up-regulation of the system. Therefore, hyper-osmotic induced cell shrinkage 
in skeletal muscle could potentially result in increased activation of the ubiquitin 
proteasome system as well as an increase in total protein degradation.  
IIIb. The Calpain System 
The calpain system is another major protein degradation pathway found in 
skeletal muscle (Dayton, Goll et al. 1976). Calpains are cysteine proteases which 
are activated by the presence of  Ca2+ (Guroff 1964). Three different calpains are 
found in skeletal muscle: the ubiquitous µ-calpain and m-calpain, and the muscle 
specific p94 (Goll, Thompson et al. 2003; Bartoli and Richard 2005). There has 
been limited research conducted on p94 due to the technical difficulty in isolating 
the isoform. p94 has also been shown to undergo rapid autocatalytic degradation 
after protein translation which makes it a challenge to detect and quantify in 
skeletal muscle (Sorimachi, Toyama-Sorimachi et al. 1993). In addition, there 
remains debate in the literature about the role Ca2+ plays in its activation. Some 
believe that p94 activation is Ca2+ dependent while others believe that it can be 
activated in the absence of Ca2+. Further research on p94 is required.  
Calpains have several functions within muscle including cell migration, 
apoptosis, cell proliferation as well as myofibrillar protein degradation. They have 
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been speculated to be localized around the Z-disk region in skeletal muscle 
(Kumamoto, Kleese et al. 1992). µ and m calpains are homologous heterodimers 
composed of an 80kDa unit and 30kDa subunit. The larger subunit contains the 
catalytic domain while the smaller subunit is responsible for regulatory functions 
(Smith, Lecker et al. 2008). The major difference between the two isoforms is the 
Ca2+ concentration required for activation. µ calpain requires approximately 3-50 
µM free Ca2+ while m calpain requires approximately 400-800 µM free Ca2+ to 
achieve ½ proteolytic activity (Pontremoli, Viotti et al. 1990; Melloni, Michetti et 
al. 1998; Goll, Thompson et al. 2003). In skeletal muscle, resting cytosolic Ca2+ 
concentration hovers around 100 nM, with increases up to 3-15 µM during an 
action potential (Williams, Head et al. 1990; Delbono and Stefani 1993). Since 
physiological Ca2+ peak tetanus does not reach the threshold for m calpain 
activation, µ calpain will be the focus for this study.  
Although there has been extensive research on calpain activation in a 
variety of cell types, the mechanism is still debated within the academic 
community. The following mechanism has been most accepted by researchers. 
As intracellular Ca2+ concentrations rise, calpain will translocate to the cell 
membrane where µ calpain will either bind a) a cell membrane phospholipid or b) 
a free Ca2+ molecule. Evidence has shown that phospholipids within the cell 
membrane, specifically the acidic phosphatidylinositol (PI), phosphatidylserine 
(PS) and phosphatidylcholine (PC), have the potential to enhance µ calpain 
activation by lowering the Ca2+ threshold required for activation (Coolican and 
Hathaway 1984; Pontremoli, Melloni et al. 1985; Chakrabarti, Dasgupta et al. 
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1990). The proposed involvement of phospholipids is not completely supported 
as a physiological mechanism has yet to be established, therefore further 
research is necessary. Once µ calpain has bound to either a membrane 
phospholipid or a free Ca2+ molecule,  µ calpain will undergo a conformational 
change resulting in the dissociation of its 80kDa and 30kDa subunits (Suzuki, 
Hata et al. 2004). Paired with this dissociation, is a self-digestion of the 80kDa 
subunit  to 78kDa and 76kDa isoforms (Goll, Thompson et al. 2003). This self-
digestion is known as autolysis and is often used as indicator of calpain activity 
because of its close association with calpain activation. During autolysis, a new 
Ca2+ binding site is formed on the calpain protease domain. Ca2+ will bind to this 
newly formed site and activate µ calpain to degrade intracellular proteins (Suzuki, 
Hata et al. 2004).  
Calpastatin is the main inhibitor of calpain activity. Eight calpastatin 
isoforms have been identified to date in varying tissues, with each containing four 
inhibitory domains, capable of binding one calpain each (Imajoh, Kawasaki et al. 
1987; Parr, Sensky et al. 2001). Although an inhibitor, calpastatin still requires 
Ca2+ in order to bind to calpain (Cottin, Vidalenc et al. 1981). In fact, calpastatin 
requires less Ca2+ to bind to calpain than is required for calpain activation. To 
avoid extensive inhibition by calpastatin, the protein does not bind Ca2+ directly 
but instead is reliant on the Ca2+ associated with the calpain (Kapprell and Goll 
1989). This allows calpains to be activated as required by the cell.  
Calpains have been found to initiate the degradation of several myofibrillar 
proteins in vitro including tropomyosin, troponin I, troponin T, desmin, titin and 
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nebulin (Toyo-Oka, Shimizu et al. 1978; Huang and Forsberg 1998). Evidence 
exists to show myosin and actin are not targets of µ calpain (Toyo-Oka and 
Masaki 1979). It is believed that calpains’ role is in the initiation of myofibrillar 
protein degradation which results in the disorganization of myofibrils. From here, 
the ubiquitin-proteasome-system is proposed to take over and further degrade 
myofibrillar proteins (Solomon and Goldberg 1996).    
Before calpain activation can occur, an increase in intracellular Ca2+ 
concentration is required. However, resting skeletal muscle typically contains low 
concentrations of myoplasmic intracellular Ca2+ (~50nM), which are not great 
enough to promote calpain activity. Therefore, if calpain activity were to be 
altered during hyper-osmotic induced cell shrinkage, another source of Ca2+ is 
required. The phenomenon of Ca2+ sparks were first seen in cardiac muscle but 
their presence in skeletal muscle has subsequently been discovered (Cheng, 
Lederer et al. 1993; Tsugorka, Rios et al. 1995). Ca2+ sparks are brief and 
localized increases in myoplasmic Ca2+ concentrations and occur in the absence 
of an action potential. One of the known causes of spontaneous Ca2+ sparks is 
an extracellular hyper-osmotic environment. Researchers have found that 
isolated and intact skeletal muscle fibers which were exposed to a hyper-osmotic 
solution exhibited Ca2+ sparks (Martin, Petousi et al. 2003; Wang, Weisleder et 
al. 2005). Researchers have proposed that hyper-osmotic induced cell shrinkage 
results in an alteration of the structural interaction between DHPR and ryanodine 
receptors resulting in the spontaneous release of Ca2+ from the SR (Apostol, 
Ursu et al. 2009). In support of their hypothesis, the inhibition of DHPR activation 
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resulted in the suppression of Ca2+ sparks, which suggests that the Ca2+ sparks 
are being released from intracellular sources (Pickering, White et al. 2009). 
 The role of calpains within skeletal muscle protein degradation has been 
examined extensively in the past and evidence exists to show that they do play a 
role in the degradation of sarcomeric proteins (Huang and Forsberg 1998; Goll, 
Thompson et al. 2003). The phenomenon of Ca2+ sparks in skeletal muscle 
during hyper-osmotic stress makes calpains an obvious candidate for up-
regulation in hyper-osmotic stress.  
IV. Protein Synthesis 
Protein synthesis is the process of building new proteins to replace old or 
dysfunctional proteins. Before transcription and translation can occur, signalling 
cascades must be initiated to stimulate the synthesis of specific proteins which 
are required by the cell. One of the primary protein synthesis signalling pathways 
in skeletal muscle is the Akt/mTOR/p70s6k pathway. Increased activity of this 
pathway has been shown to result in hypertrophy while decreased flux through 
the pathway leads to skeletal muscle atrophy (Bodine, Stitt et al. 2001).  
At the whole body level, the regulation of protein synthesis begins with 
amino acid availability as they are the building blocks of all proteins (Millward, 
Nnanyelugo et al. 1974). However, certain hormones and growth factors (e.g. 
IGF-1 and insulin), also have influence on activity of the Akt/mTOR/p70s6k 
pathway. Upon the binding of IGF-1 and insulin to their respective receptors on 
the cell membrane, phosphatidylinositol-3-kinase (PI3K) is activated. Once PI3K 
is activated, it then will phosphorylate a membrane phospholipid, 
30	  
	  
phosphatidylinositol-4, 5-bisphosphate, to generate phosphotidylinositol-3, 4, 5-
trisphosphate; this action results in the formation of a binding site on 
phosphatidylinositol-3, 4, 5-trisphosphate for Akt (Vivanco and Sawyers 2002; 
Matsui, Nagoshi et al. 2003). Akt is a major serine/threonine kinase that is 
involved in skeletal muscle protein synthesis through several routes of action. For 
Akt activation to occur, Akt must translocate to the cell membrane and bind to 
phosphotidylinositol-3, 4, 5-trisphosphate which results in its phosphorylation 
(Stitt, Drujan et al. 2004). During models of skeletal muscle hypertrophy, the 
proportion of phosphorylated Akt has been shown to be increased. Conversely, 
rodent hind-limb suspension models have shown decreases in Akt 
phosphorylation (Lai, Gonzalez et al. 2004).  
Downstream from Akt, there are three main targets, all of which influence 
protein synthesis. GSK-3-β (glycogen synthase kinase-3-beta) is responsible for 
the synthesis of glycogen within skeletal muscle, but also blocks protein 
translation when in its active form (Rommel, Bodine et al. 2001). Phosphorylated 
Akt has been shown to inhibit the activation of GSK-3-β in myotubes (Cross, 
Alessi et al. 1995). FOXO (Forkhead Box Proteins) are another downstream 
target of Akt. FOXO proteins are transcription factors in skeletal muscle that 
translocate to the nucleus upon activation and act to influence gene expression. 
FOXO proteins appear to aid in the up-regulation of E3 ligases, MuRF-1 and 
Atrogin-1 (Sandri, Sandri et al. 2004). As previously mentioned, MuRF-1 and 
Atrogin-1 are involved in the process of poly-ubiquitination in skeletal muscle. 
Activated Akt has been shown to inhibit the translocation of FOXO proteins to the 
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nucleus thereby negating their effect on the E3 ligases. Conversely, when Akt is 
inactive, FOXO proteins are free to translocate to the nucleus and increase E3 
ligase expression (Leger, Cartoni et al. 2006). The final and most important 
downstream target of Akt is mammalian target of rapamyacin (mTOR). mTOR is 
another serine/threonine kinase that is heavily involved in protein synthesis within 
skeletal muscle. It is phosphorylated/activated by phospho-Akt (Miyazaki and 
Esser 2009). mTOR is considered to be a central sensor of multiple stimuli such 
as environmental and metabolic information (i.e. amino acid availability, 
extracellular milieu, ATP availability) (Kimball, Jefferson et al. 2000; Dennis, 
Jaeschke et al. 2001). To investigate the role of mTOR in skeletal muscle 
hypertrophy, researchers often make use of a pharmacological blocker of mTOR, 
rapamyacin, to inhibit its activation. Using this approach with an in-vivo and in-
vitro skeletal muscle model, hypertrophy was found to be blunted in both cases 
(Bodine, Stitt et al. 2001; Rommel, Bodine et al. 2001). Furthermore, evidence 
has shown that increases and decreases of phosphorylation at a specific mTOR 
residue (Ser 2448) were associated with skeletal muscle hypertrophy and 
atrophy, respectively (Reynolds, Bodine et al. 2002). In scientific models of cell 
shrinkage, mTOR activation has been shown to decrease when cultured 
lymphocyte cells were exposed to hyper-osmotic stress. As the cells were 
returned to iso-osmotic conditions, mTOR activation returned to baseline values 
(Fumarola, La Monica et al. 2005). In skeletal muscle models of cell shrinkage 
(e.g. rodent hind-limb suspension), phosphorylation at Ser 2448 has been shown 
to be significantly diminished (Reynolds, Bodine et al. 2002). In addition, 
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reductions of intracellular ATP levels have been shown to inhibit mTOR 
activation; previous research has revealed that an extracellular hyper-osmotic 
environment causes a reduction in intramuscular ATP levels (Dennis, Jaeschke 
et al. 2001; Antolic, Harrison et al. 2007). Based on these observations, mTOR 
phosphorylation may be decreased during hyper-osmotic stress in isolated intact 
skeletal muscle.  
Downstream from mTOR there are three main targets: MuRF-1/Atrogin-1, 
eIF-4EBP1 and p70s6 kinase. Similar to Akt, mTOR activation has been shown 
to inhibit the up-regulation of MuRF-1 and Atrogin-1, except independently of 
FOXO proteins (Latres, Amini et al. 2005). Another downstream target of mTOR 
is eIF-4EBP1 (eukaryotic translation initiation factor 4E-binding protein 1). eIF-
4EBP1 is a protein which binds to eIF-4E (eukaryotic translation initiation factor 
4E) and inhibits its ability to initiate protein translation. Activated mTOR has been 
shown to alleviate the inhibition of eIF-4EBP1 on eIF-4E, thereby promoting 
protein translation (Hara, Yonezawa et al. 1997). The final downstream target of 
mTOR is p70s6 kinase. p70s6 kinase is another serine/threonine kinase that is 
involved in skeletal muscle protein synthesis. It is phosphorylated and activated 
by phospho-mTOR. Following its phosphorylation, p70s6k has been shown to 
phosphorylate/activate S6 ribosomal protein, which is responsible for protein 
translation at the level of the ribosomes (Baar and Esser 1999). Research has 
elucidated the phosphorylation of residue Thr 389 as mTOR-dependent as well 
as an important phosphorylation site for optimal p70s6 kinase activity (Pearson, 
Dennis et al. 1995; Burnett, Barrow et al. 1998). In models of cell shrinkage, 
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p70s6 kinase phosphorylation has been shown to be decreased. In both 
lymphocyte and mouse myeloma cell culture, hyper-osmotic stress was shown to 
reduce p70s6 kinase and ribosomal S6 phosphorylation (Kruppa and Clemens 
1984; Fumarola, La Monica et al. 2005). In skeletal muscle models of cell 
shrinkage (e.g. hind-limb suspension, microgravity) similar findings have been 
observed. Spaceflight has been shown to reduce flux through the 
Akt/mTOR/p70s6k pathway, while hind-limb suspension has been shown to 
result in a decrease of phosphorylated p70s6 kinase (Hornberger, Hunter et al. 
2001; Allen, Bandstra et al. 2009). Based on these observations, p70s6 kinase 
phosphorylation levels are likely to decrease in intact isolated skeletal muscle 
when placed under extracellular hyper-osmotic stress.  
The Akt/mTOR/p70s6 kinase protein synthesis signalling pathway is one 
of the primary pathways in skeletal muscle. Scientific models of cell shrinkage 
suggest that hyper-osmotic induced cell shrinkage in skeletal muscle could lead 
to decreased activity within the pathway and an overall suppression of protein 
synthesis. A detailed figure of the Akt/mTOR/p70s6k protein synthesis pathway is 
featured below as well as hypothesized findings of the current study (See Figure 
6). 
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FIGURE 6. Summary of hypothesized findings of the Akt/mTOR/p70s6k protein 
synthesis pathway, ubiquitin proteasome system, and calpain system in skeletal 
muscle during extracellular hyper-osmotic stress (Adapted from (Glass 2005)) 
	  
V. Summary 
It has long been established that cell volume is dynamic in nature in a 
variety of cell types, including skeletal muscle. Cell volume changes have been 
shown to influence cellular processes, specifically metabolic activity. The theory 
of cell swelling states, cellular swelling will lead to an anabolic intracellular 
environment while cellular shrinkage will create a catabolic intracellular 
environment. Although the purpose of these metabolic alterations is unknown, 
they have been hypothesized to serve as a form of osmoregulation. Hyper-
osmotic induced cell shrinkage and protein turnover has been heavily researched 
in hepatocytes but little work has been conducted in skeletal muscle despite its 
large store of functional protein. Recently, researchers found hyper-osmotic 
environment results in a suppression of total protein synthesis in muscle cell 
culture (Roy 2009), however protein degradation was not measured, nor were 
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specific signalling proteins in the protein synthesis and degradation pathways. In 
addition, an intact skeletal muscle model would provide a much more 
physiological understanding of the effects of hyper-osmotic stress on protein 
turnover.  
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CHAPTER 2: STATEMENT OF THE PROBLEM 
	  
I. Statement of the Problem  
Currently, it is known that protein metabolism is altered in skeletal muscle 
cell culture when exposed to extracellular hyper-osmotic stress. Specifically, an 
extracellular hyper-osmotic environment results in a suppression of total protein 
synthesis. However, it is unknown whether the findings in cell culture will 
translate to an intact isolated skeletal muscle model. In addition, the effects of 
extracellular hyper-osmotic stress on total protein degradation, ubiquitinated 
protein, calpain autolysis and mTOR/p70s6k phosphorylation in skeletal muscle 
are unknown.    
II. Purpose 
 The purpose of this thesis is to:  
1) Determine the influence of an extracellular hyper-osmotic environment on 
overall protein synthesis and degradation in intact isolated rat skeletal muscle 
2)  Investigate the influence of an extracellular hyper-osmotic environment on 
protein degradation pathways; specifically the ubiquitin proteasome pathway 
and the calpain system. 
3) Investigate the influence of an extracellular hyper-osmotic environment on the 
Akt/mTOR/p70s6k protein synthesis signalling pathway. 
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III. Hypotheses 
It is hypothesized that extracellular hyper-osmotic stress will: 
1) Result in an overall increase in protein degradation and a suppression of 
total protein synthesis. 
2) Result in an up-regulation of protein degradative mechanisms, specifically: 
1) in the amount of ubiquitinated proteins and 2) in the amount of µ calpain 
autolysis. 
3) Result in a suppression of protein synthesis signalling mechanisms, 
specifically: 1) in the amount of mTOR Ser 2448 phosphorylation and 2) in 
the amount of p70s6k Thr 389 phosphorylation. 
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CHAPTER 3: METHODOLOGY 
I. Animals and Housing 
Eight Long Evans rats (Charles River Laboratories, St. Constant, QC) 
aged 4-6 weeks (127.45 ±	  2.95	  g), were used for total synthesis measures. An 
additional eight Long Evans rats (Charles River Laboratories, St. Constant, QC) 
of similar age (128.3 ±	  1.94	  g) were used for degradation/metabolite/intracellular 
water content/Western blotting analyses (See Figure 7). Animals were housed in 
groups (2-4 rats per cage) within the Brock University Animal Facility, and were 
maintained on a 12:12 light-dark cycle at ~22ºC. The rats were fed a standard 
rodent diet (5012 Rat diet, PMI nutrition Inc LLC, Brentwood, MO) and had ad 
libitum access to food and water. All experimental procedures and protocols were 
approved by the Brock University research subcommittee on animal care and 
conformed to all Canadian Council on Animal Care guidelines.  
 
 
FIGURE 7. Experimental Design  
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II. Osmotic Conditions	  
Two different experimental osmotic conditions were used for muscle 
incubations: a hyper-osmotic (HYPER; 400 ± 10 mmol/kg) and an iso-osmotic 
(ISO; 290 ± 10 mmol/kg). These osmotic conditions have been previously 
developed in our lab and have routinely been used for both soleus and extensor 
digitorum longus (EDL) whole muscle incubations (Antolic, Harrison et al. 2007). 
In the current study, a custom modified media based off Sigma Medium 199 
(Gibco) was used for incubations. Tyrosine and phenol red were removed from 
the media (see Appendix II for detailed description of Custom Media). Mannitol 
was added to the media immediately prior to incubations to achieve desired 
osmolalities in the HYPER group. Mannitol was used to manipulate osmolality 
due to its ability to rapidly equilibrate in solution and its inability to enter 
intracellular compartments (Stuart, Torres et al. 1970). The osmolality of all 
incubation media was verified using a vapour pressure osmometer 
(VAPRO5520, Wescor, Logan, UT).  
III. Muscle Extraction	  
The predominantly fast-twitch EDL muscle was used for incubations 
because of its responsiveness to varying osmotic environments (Delp and Duan 
1996; Antolic, Harrison et al. 2007). All incubations were conducted at 10-11am, 
and access to chow was removed 2 hours before muscle extraction to minimize 
dietary induced alterations in protein metabolism. Rats were then anesthetized 
with an intraperitoneal injection of sodium pentobarbital (55 mg·kg-1) and EDL 
muscles were dissected free tendon to tendon (Antolic, Harrison et al. 2007). 
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Briefly, the skin covering the ankle was cut and peeled back, exposing the leg 
muscles underneath. A small incision through the fascia and superficial muscle 
groups (tibialis anterior/peroneus longus) was made from the lateral side of the 
patella to the lateral malleolus, exposing the EDL. The EDL was then delicately 
teased out from tendon to tendon with forceps and silk sutures (4-0) were tied to 
the tendons in situ. Once the muscle was properly fastened, it was excised and 
quickly secured within the organ bath (< 10 sec) (Radnoti Glass Technology Inc., 
Monrovia, CA) containing approximately 15 ml of the appropriate media (See 
Figure 8). The muscle was secured on one end to a hook and then hung from a 
force transducer (Grass Telefactor, West Warwick, RI). The length of the muscle 
was then adjusted until there was 1 g of resting tension. Organ baths were kept 
at a constant temperature (30°C ± 2°C) while the media was perfused with a gas 
mixture containing 95% O2, 5% CO2. 30°C ± 2°C has been previously shown to 
maintain viability of similar sized muscles (Segal and Faulkner 1985; Antolic, 
Harrison et al. 2007). Once both EDL muscles were removed, animals were 
euthanized with an overdose of sodium pentobarbital.  
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FIGURE 8. Muscles are secured to a ‘Boomer Box’ inside the incubation bath. 
The apparatus provides an attachment for the sutures tied to the muscle 
(Adapted from (Antolic, Harrison et al. 2007). 
 
IV. Protein Turn-over Measures 
 To determine total protein synthesis in isolated skeletal muscle during 
extracellular osmotic stress, L-[14C]-U-phenylalanine uptake and incorporation 
into muscle were measured. Following a 60 min pre-incubation in either ISO or 
HYPER conditions, media was drained and replaced with identical media except 
for the addition of 0.5mmol/L L-[14C]-U-phenylalanine (9.25MBq/L), and 
subsequently incubated for an additional 75 minutes. Following the second 
incubation, muscles were removed; frozen in liquid nitrogen and stored at -80°C 
for future analysis. 
Frozen muscles were homogenized in 0.61 mol/L trichloroacetic acid 
(TCA) and centrifuged at 10,000 x g for 10 min at 4 °C to isolate the protein 
fraction (Marzani, Balage et al. 2008). The resulting pellet was then solubilized in 
1 mol/L NaOH at 37 °C and analyzed for	  14C isotopes through scintillation 
counting to determine incorporated phenylalanine (LS Multi Purpose Scintillation 
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Counter, Beckman Coulter, Mississauga, ON). Total protein synthesis was 
calculated by dividing the protein-bound radioactivity by the specific activity of 
free phenylalanine in the incubation medium and expressed as nmol of 
phenylalanine/mg protein/75 min (Dardevet, Sornet et al. 2000).  
To measure protein degradation, muscles underwent the same 60 min 
pre-incubation in either HYPER or ISO media. After 60 min, the media was 
replaced with an identical media; except for the addition of 0.5mmol/L 
cycloheximide, muscles were then incubated for an additional 75 min. 
Cycloheximide was added to the media as it prevents amino acid re-
incorporation into skeletal muscle tissue. Cycloheximide exerts its effect by 
inhibiting the transfer of amino acids from aminoacyl tRNA to peptides at the 
ribosome (Ennis and Lubin 1964). At the end of the 75 min incubation, a 2mL 
aliquot of media was collected and analyzed for tyrosine concentration. The 
appearance of tyrosine in the media was used as a measure of total protein 
degradation, as tyrosine cannot be synthesized or degraded within muscle. 
Tyrosine concentrations were determined biochemically using previously 
described methods (Waalkes and Udenfriend 1957). Briefly, 1mL of 1-nitroso-2-
naphthol and 1mL of a nitric acid reagent were added to 2mL of sample media 
where it was then stoppered, shaken and placed in a 65°C water bath for 30 min. 
Upon cooling, 10mL of ethylene dichloride was added and the mixture was 
shaken. The mixture was then centrifuged for 10 min at 2000rpm at 4°C and the 
supernatant aqueous layer was taken and analyzed via fluorometery. The 
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sample was activated at 460nm and was measured at 570nm. To determine 
tyrosine release from the muscle, samples were run against a standard curve.  
V. Western Blotting Analysis: 
Western blotting analyses was performed on samples to determine the 
content and/or phosphorylation state of major protein synthesis and degradation 
signalling pathway proteins. This was achieved through the use of antibodies 
raised against the specific proteins and phospho-proteins of interest: rabbit 
polyclonal mTOR (# 2972S, Cell Signalling, Danvers, MA), rabbit monoclonal 
phospho-mTOR Ser2448 (#2971S, Cell Signalling, Danvers, MA), rabbit 
polyclonal p70 s6 kinase α (#sc-230, Santa Cruz Biotechnology, Santa Cruz, 
CA), goat monoclonal phospho-p70 s6 kinase α Thr389 (#sc-11759, Santa Cruz 
Biotechnology, Santa Cruz, CA), rabbit polyclonal µ calpain (#2556S, Cell 
Signalling, Danvers, MA), rabbit polyclonal ubiquitin protein conjugates 
(#UG9510, Enzo Life Sciences, Farmingdale, NY) and mouse monoclonal actin 
(#612656, BD Biosciences, Mississauga, ON). Ubiquitin conjugates were 
analyzed in relation to total actin where as phospho-p70 s6 kinase α Thr389 and 
phospho-mTOR Ser2448 were analyzed in relation to total p70s6 kinase and 
total mTOR, respectively. Autolysis of µ calpain was represented as the 
increasing appearance of the lower bands at 78 and 76 kDa while the higher 80-
kDa band represents un-autolyzed µ calpain. Each antibody was tested prior to 
analysis to optimize protein load. 
Samples were homogenized by hand in an ice cold buffer (250mM 
sucrose, 100mM KCl, 10mM EGTA) with the addition of a protease inhibitor 
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(#11836170001, Roche, Laval, QC) and phosphatase inhibitor (#04906837001, 
Roche, Laval, QC). Following homogenization, a Bradford assay was run to 
determine protein concentration and samples were then diluted with H2O and a 
sample buffer ( 0.5M Tris-HCl, 2mL glycerol, 10% SDS, 1% bromophenol blue, 
1mL β-mercaptoethanol, and dH2O) to a final protein concentration of 1 GAWul-1. 
Standard SDS-PAGE electrophoresis was performed with the use of 7.5% 
(mTOR, phospho-mTOR, µ calpain and ubiquitin protein conjugates) or 10% (p70 
s6 kinase, phospho-p70 s6 kinase) separating gel and loaded with 8 - 20 µl of 
protein. Molecular weight standards were also included alongside samples on 
each gel (#161-0375, BioRad, Mississauga, ON). Samples were run for 
anywhere from 75-120 minutes at 100-160V depending on the specific protein 
(See Appendix). Electrophoretically separated proteins were then transferred to 
either nitrocellulose membrane (µ calpain) or polyvinylidene fluoride membrane 
(PVDF) (mTOR, phospho-mTOR, ubiquitin protein conjugates, p70 s6 kinase and 
phospho-p70 s6 kinase) for 75-120 minutes at 100V in a transfer buffer (1.25% 
SDS, 312.5mM Tris Base, 2.4M glycine, 20% methanol). Following transfer, 
membranes were blocked in a blocking solution to prevent non-specific binding, 
in either 5% (w/v) BSA (bovine serum albumin) or 5% (w/v) non-fat dry milk-
TBST solution (TBST buffer: 20mM tris base, 137mM NaCl, and 0.1% (v/v) 
tween 20, pH 7.5) for 60 minutes at room temperature. Membranes were then 
washed 5 times for 5 minutes each with TBST buffer. Following this series of 
washes, membranes were incubated overnight with the appropriate antibody 
dilution. Dilutions were determined via pilot work. Antibodies were placed in 
45	  
	  
either a 1-5% milk TBST solution or a 1% (w/v) BSA in PBST solution (PBST 
buffer: 137mM NaCl, 3mM KCl, 10mM Na2HPO4, 2mM KH2PO4, 0.05% (v/v) 
tween 20, pH 7.2) depending on protein. Membranes were rocked overnight at 
4°C. Post primary antibody incubation, membranes were again washed 5 times 
for 5 minutes each with TBST buffer to remove unbound antibody. Following 
these washes, membranes were incubated for 1 hour at room temperature with 
an appropriate HRP conjugated secondary antibody at the appropriate dilution. 
This was followed by another series of washes in TBST buffer (5 X 5min). 
Membranes were then treated with Chemi Glow West Substrate (#WBKLS0500, 
Billerica, MA) for 5 minutes, developed using the FluroChem imaging system 
(Alpha-Innotec, Santa Clara, CA), and quantified using the AlphaEaseFC 
Software (Alpha-Innotec, Santa Clara, CA). Band density was determined with 
“Image J” software (National Institutes of Health, Bethesda, MD).  
VI. Metabolite Analysis: 
For metabolite analysis, a small portion of frozen muscle was chipped off, 
dehydrated, powdered and removed of any connective tissue or blood. The 
powdered sample was then acid extracted for quantification of; adenosine 
triphosphate (ATP) and phospho-creatine (PCr). Previously described 
flourometric techniques were used to analyze the concentrations of the 
metabolites (Harris, Hultman et al. 1974; Green, Thomson et al. 1987). To assure 
accuracy and reliability of the measures, each sample was analyzed in triplicate 
during the same experimental session. 
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VII. Statistical Analysis  
 All data were analyzed using independent samples t tests to compare the 
means of the two experimental groups; ISO and HYPER. The level of statistical 
significance was set at p≤0.05 for all analysis.  All statistical analyses were 
conducted using GraphPad Prism 5 (La Jolla, CA) and all values are expressed 
as the means ± standard error (SE). 
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CHAPTER 4: RESULTS 
I. General Observations  
No statistical differences were observed between the weights of the rats in 
each experimental condition (see Table 1). Media osmolality measured prior to 
incubation fell within ± 10 GGIFWEA-1 of the respective target osmolalities. At this 
time, the HYPER condition osmolality was found to be significantly (p<0.05)	  
higher than the ISO condition. 
 
Table 1: Rat Weights and Media Osmolalities  
Experimental Group 
 
Rat Weight (g) Osmolality 
ISO 
HYPER 
125.1 ± 1.7 
130.6 ± 2.9 
285.4 ± 1.2 
394.3 ± 0.7* 
Note: Values are expressed as mean ± SE (n = 16 muscles per group). * 
Significantly different (p<0.05) from ISO. 
 
	  
II. Relative Water Content 
 Following the 60 min pre-incubation and 75 min incubation, relative water 
content of the muscle was found to be significantly (p<0.05) decreased (4.1%) in 
the HYPER condition as compared to ISO (see Figure 9). 
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FIGURE 9. EDL water content during hyper-osmotic stress. Values are 
expressed as means ± SE (n = 7 per group). * Significantly different (p<0.05) 
from ISO.  
 
III. Metabolites 
In the EDL muscle, both ATP and PCr concentrations were significantly 
(p<0.05) lower in the HYPER condition compared to ISO (see Table 2).   
 
Table 2: High Energy Phosphate Metabolite Concentrations 
Experimental Group 
 
ATP PCr 
ISO 
HYPER 
32.1 ± 0.4 
30.0 ± 0.6* 
77.7 ± 0.4 
37.2 ± 0.6* 
Note: All values were derived from EDL muscles. All values expressed in 
GGIFWEA-1 dry wt. n = 7 for each group. ATP = adenosine triphosphate, PCr = 
phosphocreatine. * Significantly different (p<0.05) from ISO. 
	  
IV. Protein Synthesis  
	   Incorporated phenylalanine was found to be significantly (p<0.05) lower 
(41%) in the HYPER condition compared to the ISO control (See Figure 10). 
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FIGURE 10. Incorporated phenylalanine in skeletal muscle during iso-osmotic 
and hyper-osmotic stress. Values are expressed as means ± SE (n = 8 per 
group). * Significantly different (p<0.05) from ISO. 
 
V. Protein Degradation 
 Tyrosine release was found to be significantly (p<0.05) increased (43%) 
in the HYPER condition compared to ISO (see Figure 11). 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  
FIGURE 11. Protein degradation as estimated by tyrosine release from skeletal 
muscle during iso-osmotic and hyper-osmotic stress. Values are expressed as 
means ± SE (n = 8 per group). * Significantly different (p<0.05) from ISO. 
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VI. Western Blotting Analyses 
	   Total mTOR protein content was found to be similar in both experimental 
groups (see Figure 12). However, the amount of mTOR phosphorylation in 
relation to total mTOR was found to be significantly (p<0.05) increased (15%) in 
the HYPER condition (see Figure 13). Total p70s6 kinase protein content was 
found to be similar in both experimental groups (see Figure 14) while p70s6 
kinase phosphorylation in relation to total p70s6 kinase content was found to be 
significantly (p<0.05) decreased (23%) in the HYPER condition compared to ISO 
control (see Figure 15). 
 Total actin in skeletal muscle was found to be consistent between the ISO 
and HYPER groups (see Figure 16). The amount of ubiquitinated protein in 
relation to total actin was also found to be consistent between the ISO and 
HYPER conditions (see Figure 17). Unautolyzed µ calpain (80kDa) was found to 
be significantly (p<0.05) decreased in the HYPER condition compared to ISO 
control (see Figure 18). Autolyzed µ calpain (78/76 kDa) was found to be 
significantly (p<0.05) increased in HYPER compared to the ISO control (see 
Figure 18). 
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FIGURE 12. Total mTOR protein content in skeletal muscle during iso-osmotic 
and Hyper-osmotic Stress. Values are expressed as means ± SE (n = 8 per 
group).  
	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  
	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	                             	  
FIGURE 13. mTOR phosphorylation in relation to total mTOR in skeletal muscle 
during iso-osmotic and hyper-osmotic Stress. Values are expressed as means ± 
SE (n = 8 per group). * Significantly different (p<0.05) from ISO. 
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FIGURE 14. Total p70s6 kinase content in skeletal muscle during Iso-osmotic 
and Hyper-osmotic Stress. Values are expressed as means ± SE (n = 8 per 
group). 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
FIGURE 15. p70s6 kinase phosphorylation in relation to total p70s6 kinase in 
skeletal muscle during iso-osmotic and hyper-osmotic stress. Values are 
expressed as means ± SE (n = 8 per group). * Significantly different (p<0.05) 
from ISO.  
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FIGURE 16. Total actin protein content in skeletal muscle during iso-osmotic and 
hyper-osmotic stress. Values are expressed as means ± SE (n = 4 per group).  
	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  
FIGURE 17. Total ubiquitinated protein in relation to total actin in skeletal muscle 
during iso-osmotic and hyper-osmotic stress. Values are expressed as means ± 
SE (n = 4 per group).  
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FIGURE 18. Unautolyzed (80kDa) and autolyzed (78/76kDa) calpain in skeletal 
muscle during iso-osmotic and hyper-osmotic stress. Values are expressed as 
means ± SE (n = 6 per group). α Significantly different (p<0.05) from ISO – 
80kDa. * Significantly different (p<0.05) from ISO – 78/76kDa.   
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CHAPTER 5: DISCUSSION 
Many studies have examined the effect of hyper-osmotic stress on protein 
turnover in whole body and hepatocyte models, but few have examined the effect 
in skeletal muscle (Haussinger, Hallbrucker et al. 1991; Stoll, Gerok et al. 1992; 
Berneis, Ninnis et al. 1999; Roy 2009). Furthermore, the few studies that have 
investigated skeletal muscle used varying models. To the authors knowledge the 
current study is the first to have utilized used an isolated intact skeletal muscle 
model. Given that this is the first known study to have used this particular model 
to examine protein turnover under extracellular hyper-osmotic stress, 
comparative literature is limited.    
The primary finding of the current study was the influence of extracellular 
hyper-osmotic stress on protein turnover in skeletal muscle. Extracellular hyper-
osmotic stress was shown to suppress protein synthesis as well as stimulate 
protein degradation. The expression of major protein synthesis and degradation 
signalling pathway proteins were generally in agreement with the protein turnover 
data. Contrary to our hypotheses, mTOR Ser 2448 phosphorylation was found to 
increase while ubiquitin conjugates were unchanged during extracellular hyper-
osmotic stress. In support of our hypotheses, p70s6 kinase Thr 389 
phosphorylation was decreased while µ calpain autolysis was increased during 
extracellular hyper-osmotic stress. Overall, these results suggest that osmotically 
induced decreases of cell volume influence protein turnover in an intact skeletal 
muscle model and promote an intracellular protein catabolic environment.  
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I. General Observations 
 Intact isolated skeletal muscle that is exposed to extracellular hyper-
osmotic stress has been shown to result in a decline of cell volume (Antolic, 
Harrison et al. 2007; Mulligan 2008). These findings were confirmed in the 
current study. The 60 minute pre-incubation and 75 minute incubation in hyper-
osmotic media resulted in a 4.1% decrease in intracellular water content (p<0.05) 
compared to the iso-osmotic control. The intracellular water loss observed in the 
current study was similar to previous studies within our lab despite an additional 
75 minutes of incubation time (Antolic, Harrison et al. 2007; Mulligan 2008). This 
suggests that RVI processes were likely complete by 60 minutes of incubation 
time and the incubated muscles were at a new stable equilibrium volume.  
The present work also demonstrated a significant (p<0.05) decrease of 
intramuscular ATP and PCr concentrations during extracellular hyper-osmotic 
stress. These findings were in agreement with previous work conducted within 
our lab (Antolic, Harrison et al. 2007). The reduction of intramuscular ATP and 
PCr concentrations could be attributed to several factors. First of all, the 
macromolecular crowding experienced during hyper-osmotic induced cell 
shrinkage, known to influence intracellular protein activity, could negatively 
influence energy producing pathways within the cell (Garner and Burg 1994). 
Another possible explanation involves the theory of cell swelling. The 
degradation of intracellular molecules increases intracellular osmolality, therefore 
the breakdown of ATP and PCr may have been used as an acute volume 
regulatory mechanism to help increase intracellular osmolality and prevent 
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further water loss (Antolic, Harrison et al. 2007). Finally, the reduction of 
intramuscular ATP and PCr concentrations could have been the result of 
increased energy demand. There are three main consumers of ATP in skeletal 
muscle: Na+/K+ ATPase, Ca2+ ATPase and acto-myosin ATPase. Since the 
muscle was not producing force, it is likely that acto-myosin ATPase was not a 
significant user of ATP during the experiment. The primary role of Na+/K+ 
ATPase is to maintain an electrochemical gradient at the sarcolemma but it also 
serves as an indirect form of osmoregulation. During RVI, NKCC1 is activated to 
transport 2 Na+, K+ and Cl- into the cell in an attempt to increase intracellular 
osmolality; it is hypothesized that the Na+/K+ transporter is activated shortly after 
to maintain the electrochemical gradient in spite of the mass ion entry (Lindinger, 
Hawke et al. 2002). Ca2+ ATPase is also a candidate for increased activity during 
hyper-osmotic stress due to the phenomenon of Ca2+ sparks. Research has 
shown that extracellular hyper-osmotic stress results in transient increases of 
intracellular Ca2+ concentration in skeletal muscle (Apostol, Ursu et al. 2009). It is 
suggested that these Ca2+ sparks are the result of a mechanical disruption 
between DHPR and ryanodine receptors during cell shrinkage. With this 
suspected increase of intramuscular Ca2+ concentration during extracellular 
hyper-osmotic stress, Ca2+ ATPase activity could be increased as it works to 
transfer Ca2+ from the cytosol to the SR. In summary, ATP and PCr 
concentrations were likely reduced due to an increased energy demand within 
the muscle during extracellular hyper-osmotic stress. It is likely due to multiple 
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sources, specifically increased activity of Na+/K+ ATPase and Ca2+ ATPase due 
to volume regulatory mechanisms and Ca2+ sparks, respectively.       
II. Protein Synthesis 
In the current study, extracellular hyper-osmotic stress was shown to 
result in a significant (p<0.05) decrease of phenylalanine incorporation in skeletal 
muscle. The suppression of protein synthesis, as estimated by phenylalanine 
incorporation, was in accordance with findings in hepatocyte and skeletal muscle 
cell culture models (Stoll, Gerok et al. 1992; Roy 2009). These results lend 
support to the theory of cell swelling as they are indicative of an intracellular 
protein catabolic environment. In this case, hyper-osmotic induced cell shrinkage 
appears to trigger an intracellular signal cascade which eventually leads to an 
inhibition of protein synthesis in skeletal muscle. The intracellular signalling 
mechanism responsible for this suppression of protein synthesis was largely 
unknown but advancements have been made. Research has elucidated p70s6 
kinase activity as an important contributor to the suppression of protein synthesis 
during hyper-osmotic stress in both myeloma and lymphocyte cell culture 
(Kruppa and Clemens 1984; Fumarola, La Monica et al. 2005). In addition, 
investigators have established an association between p70s6 kinase 
phosphorylation at Thr 389 and hypertrophy and atrophy in skeletal muscle (Baar 
and Esser 1999; Terzis, Georgiadis et al. 2008). However, the effects of 
extracellular hyper-osmotic stress on p70s6 kinase activity in skeletal muscle 
were previously unknown. In the current study, it was determined that hyper-
osmotic induced cell shrinkage significantly (p<0.05) decreased p70s6 kinase 
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phosphorylation at Thr 389. In addition to the aforementioned literature, these 
findings are also in agreement with skeletal muscle models of cell shrinkage; 
rodent hind-limb suspension and micro-gravity models have both been shown to 
result in a decrease of p70s6 kinase phosphorylation (Hornberger, Hunter et al. 
2001; Allen, Bandstra et al. 2009). Based on these observations, it is plausible 
that the decrease of p70s6 kinase phosphorylation at Thr 389 could be 
contributing to the suppression of protein synthesis observed in skeletal muscle 
during hyper-osmotic induced in muscle cell shrinkage.  
The observed increase of mTOR phosphorylation at Ser 2448 during 
extracellular hyper-osmotic stress in skeletal muscle was not an expected 
finding. It was originally believed that mTOR phosphorylation/activation would be 
reduced due to its known role in skeletal muscle hypertrophy as well as the 
observed decrease in protein synthesis and p70s6 kinase phosphorylation within 
the current study (Bodine, Stitt et al. 2001). However, the role of mTOR in 
skeletal muscle is very diverse; it is considered to be a central sensor with many 
intracellular influences. There are five main upstream effectors of mTOR activity 
in skeletal muscle: growth factors (e.g. insulin, IGF-1), mechanical stress, energy 
status (e.g. ATP concentrations, AMPK), cellular stress (e.g. hypoxia) and amino 
acid availability (Bolster, Jefferson et al. 2004; Foster and Fingar 2010). Growth 
factors, mechanical overload and sufficient amino acid availability are considered 
to be activators of mTOR in skeletal muscle, while reductions of intracellular ATP 
and cellular stress inhibit its action (Bolster, Jefferson et al. 2004; Foster and 
Fingar 2010). In the current study, growth factors (e.g. insulin and IGF-1) were 
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absent from the experimental media and isolated EDL muscles were not 
stimulated, therefore it seems unlikely that either could be cause for increased 
mTOR phosphorylation in skeletal muscle during hyper-osmotic stress. However, 
the apparent intracellular protein catabolism suggests that the skeletal muscle 
amino acid pool may be enlarged during extracellular hyper-osmotic stress. 
Although the molecular pathway in which mTOR senses and responds to amino 
acid availability is poorly understood, research has consistently shown that an 
increase of amino acid availability results in an increase of mTOR 
phosphorylation at Ser 2448 in skeletal muscle (Anthony, Anthony et al. 2001; 
Reynolds, Bodine et al. 2002; Bolster, Vary et al. 2004). Furthermore, some 
researchers have hypothesized that amino acid availability is the dominant input 
of mTOR (Hara, Yonezawa et al. 1998; Beugnet, Tee et al. 2003; Nobukuni, 
Joaquin et al. 2005).  
During hyper-osmotic induced cell shrinkage, the skeletal muscle amino 
acid pool has been shown to be used as a means of osmoregulation (Lang, 
Busch et al. 1998; Hyde, Taylor et al. 2003). During RVI, the acute accumulation 
of ions can disrupt intracellular processes (e.g. sarcolemmal gradient, cytosolic 
pH) therefore amino acids are accumulated in the long-term to maintain cell 
function and promote water retention. However, not all amino acids exert the 
same influence on cell volume. Glutamine, glutamate, glycine, aspartate and 
taurine have been shown to have the greatest influence on cell volume (Lang, 
Busch et al. 1998). Amino acids are moved across the cell membrane by way of 
4 known skeletal muscle amino acid transporter systems: A, ASC, L and Nm 
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(Bonadonna, Saccomani et al. 1993). Each system is responsible for the 
movement of several amino acids across the membrane. In addition, all 
transporters, with the exception of L system, are Na+-dependent and carry Na+ 
across the membrane with amino acids. In terms of osmoregulation, research 
has shown that hyper-osmotic stress results in an increased expression of the 
System A amino acid transporter (Hyde, Taylor et al. 2003). The system A amino 
acid transporter is primarily responsible for the movement of glutamine, alanine, 
threonine, asparagine, serine and methionine (Bonadonna, Saccomani et al. 
1993; Hyde, Taylor et al. 2003). Based on these observations, an increase of the 
intracellular amino acid pool could be cause for the increase of mTOR 
phosphorylation at Ser 2448 in skeletal muscle during extracellular hyper-osmotic 
stress.  
Further upstream the signalling mechanism responsible for the 
suppression of protein synthesis during extracellular hyper-osmotic stress is 
much less clear. Researchers hypothesize that macromolecular crowding may 
play a role in detection of cell volume as well as in the initiation of metabolic 
signalling response (Haussinger 1996). It is believed that cellular shrinkage alters 
the concentration of cytosolic proteins (e.g. protein kinases and phosphatases) 
and subsequently determines their activity by influencing the tendency to 
associate with their substrates. This is believed to eventually result in volume-
regulatory responses as well as changes to cellular metabolism and gene 
expression. Research in hepatocytes has focused on MAP kinase regulation 
during hyper-osmotic stress as a potential link between cell volume detection and 
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protein synthesis but additional research is necessary, particularly in skeletal 
muscle (Haussinger 1996). The activation of protein degradation pathways may 
also play a role in the regulation of protein synthesis during hyper-osmotic stress 
as the liberation of amino acids could potentially influence protein synthesis 
activity.  
III. Protein Degradation 
	   In the current study, extracellular hyper-osmotic stress was shown to 
result in a significant (p<0.05) increase of protein degradation in skeletal muscle, 
as estimated by tyrosine release. These findings are in agreement with previous 
research in hepatocytes (Haussinger, Hallbrucker et al. 1991). Similar to protein 
synthesis findings, the increase of increased protein degradation is consistent 
with the theory of cell swelling. In this case, hyper-osmotic induced cell shrinkage 
creates an intracellular protein catabolic environment and leads to the 
degradation of intracellular proteins into amino acids. However, there has also 
been a lack of literature investigating the effect of extracellular hyper-osmotic 
stress on the activation of protein degradation mechanisms in skeletal muscle. 
There are two major mechanisms of protein degradation within skeletal muscle: 
the ubiquitin proteasome system and calpain system (Jackman and Kandarian 
2004). In this study, ubiquitin conjugates were found to be consistent between 
both experimental groups while µ calpain was found to have a significantly 
(p<0.05) higher percentage of autolysis in the HYPER condition.  
Based on skeletal muscle models of cell shrinkage (e.g. hind-limb 
suspension and space flight), extracellular hyper-osmotic stress was expected to 
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result in an increase in ubiquitinated protein (Bodine, Latres et al. 2001; Ikemoto, 
Nikawa et al. 2001). One reason that we may have not seen an increase in 
ubiquitin conjugates is due to the time course of action of the ubiquitin 
proteasome system. The ubiquitin proteasome system is thought to be a longer 
term mechanism of protein degradation, therefore our incubation may not have 
been long enough in duration to produce a change in ubiquitin conjugates (Attaix, 
Aurousseau et al. 1998). Another potential explanation for the ubiquitin 
conjugates results involves a potential relationship between protein synthesis 
signalling pathways and the ubiquitin proteasome system. Research has 
suggested that cross-talk can occur between protein synthesis signalling 
pathways and E3 ligases in skeletal muscle. E3 ligases that are responsible for 
poly-ubiquitination and it is not until at least four ubiquitin molecules are attached 
to a protein that it can be degraded by the proteasome (Pickart 2000). To 
investigate a potential relationship between the Akt/mTOR/p70s6 kinase protein 
synthesis pathway and E3 ligases, researchers used dexamethasone and IGF-1 
to induce skeletal muscle atrophy/cell shrinkage and hypertrophy/cell swelling, 
respectively (Stitt, Drujan et al. 2004). During dexamethasone treatment, FOXO 
proteins were activated and lead to the up-regulation of E3 ligases. Conversely, 
during IGF-1 treatment, FOXO proteins and E3 ligases were inhibited (Sandri, 
Sandri et al. 2004). In addition, it was shown that increased activity of the 
PI3K/Akt/mTOR pathway could block the atrophy-inducing effects of 
dexamethasone, specifically the up-regulation of E3 ligases (Stitt, Drujan et al. 
2004). These observations demonstrated that activity of protein synthesis 
64	  
	  
pathways can influence the activity of protein degradation pathways, specifically 
E3 ligases. To further investigate this relationship, researchers used rapamyacin 
to inhibit the action of mTOR in IGF-1 treated muscles. This action eliminated 
some of the IGF-1-mediated transcriptional changes, specifically the down-
regulation of E3 ligases (Latres, Amini et al. 2005). This action occurred 
independently of FOXO proteins. These observations suggest that mTOR plays a 
role in the down-regulation E3 ligases. In the current study, extracellular hyper-
osmotic stress resulted in an increase in mTOR phosphorylation. Therefore, it is 
possible that the increase of mTOR activation inhibited an up-regulation of 
ubiquitin conjugates. Future research should investigate changes in mRNA 
expression of E3 ligases, Atrogin-1 and MuRF-1, in a similar experimental model 
to investigate the acute activation of the ubiquitin proteasome system.  
The increase in calpain autolysis was an expected finding due to the 
known presence of Ca2+ sparks during hyper-osmotic stress in skeletal muscle 
(Apostol, Ursu et al. 2009). Calpain autolysis is closely associated with activation 
of calpain therefore an increase in autolysis is representative of its degradative 
activity (Baki, Tompa et al. 1996). Previous literature in skeletal muscle has 
shown that extracellular hyper-osmotic stress results in spontaneous transient 
increases in intracellular Ca2+ concentration (Apostol, Ursu et al. 2009). Based 
on the Ca2+-dependent regulation of calpain, these observations suggest that 
Ca2+ sparks are responsible for the increase of calpain autolysis. The 
concentration of these sparks is currently unknown but are assumed to reach the 
activation threshold of µ calpain, 3-50 µm (Goll, Thompson et al. 2003). It has 
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been suggested that hyper-osmotic stress disrupts the structural interaction 
between DHPR and ryanodine receptors to allow Ca2+ release from the SR. 
However, further research should be conducted to verify this hypothesis. 
Despite the findings of this study, there is a lack of understanding 
regarding the signalling mechanisms which link hyper-osmotic induced cell 
shrinkage to protein degradation mechanisms in skeletal muscle. Previous work 
in hepatocytes has hypothesized the microtubule network may be a key 
component in the regulation of proteolysis. In contrast to declines in cell volume, 
cellular swelling has been shown to inhibit proteolysis in hepatocytes in the 
theory of cell swelling. Researchers have attempted to elucidate the mechanisms 
underlying these findings through the induction of cell swelling with hypo-osmotic 
media, insulin and glutamine. Each of these agents were shown to increase 
tubulin mRNA levels 1.9, 2.1 and 2.7 fold, respectively (Haussinger, Stoll et al. 
1994). These findings lead researchers to believe that cellular swelling creates a 
stabilizing environment on microtubules. In a follow-up study, perfused 
hepatocytes were again exposed to hypo-osmotic media, insulin and glutamine 
but also colchicine (vom Dahl, Stoll et al. 1995). Colchicine is a microtubule 
inhibitor which binds to tubulin and prevents polymerization without affecting cell 
volume (Ai, Ralston et al. 2003). In this study, colchicine was found to abolish the 
inhibition of hepatic proteolysis induced by cell swelling in each case. 
Furthermore, perfused hepatocytes were supplied with anti-proteolytic amino 
acids which do not influence cell volume (e.g. asparagine), as well as colchicine, 
and proteolysis inhibition was found to be unaffected (vom Dahl, Stoll et al. 
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1995). This suggests that the regulation of proteolysis by way of cell volume 
alterations requires an intact microtubule network. During conditions of cell 
shrinkage, it seems likely that the microtubular network could become disrupted, 
potentially resulting in the activation of an intracellular signalling cascade 
promoting proteolysis. Although this series of studies has begun to elucidate the 
link between cell volume and proteolysis, the picture is still unclear. Future work 
should focus on establishing the mechanism responsible for control of these 
processes in other tissues such as skeletal muscle.   
Protein degradation, as estimated by intramuscular tyrosine release, was 
significantly (p<0.05) increased during extracellular hyper-osmotic stress in 
skeletal muscle. This increase may be related to the activation of the calpain 
system. These findings are in agreement with the theory of cell swelling but 
cannot be proven until research elucidates the mechanisms which link cell 
shrinkage to protein degradation pathways. Future research should also focus on 
confirming the regulation of E3 ligases by protein synthesis signalling proteins. 
IV. Summary and Conclusions  
Cell volume regulation is an extremely complex process with many 
underlying mechanisms. The link between cell volume and metabolic activity has 
been studied extensively and led to the theory of cell swelling. The theory of cell 
swelling states that cell volume acts as intracellular signal which influences 
metabolic pathways in the cell. Cell swelling results in an increase in anabolic 
activity, while cellular shrinkage leads to a catabolic cellular environment. 
Whether these metabolic fluctuations are directly related to cell volume regulation 
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or an unintended consequence remains unclear. In support of osmoregulation, 
the osmotic effect of individual amino acids is far greater than that of synthesized 
proteins; therefore inhibiting protein synthesis could theoretically increase 
intracellular osmolality, which in turn would promote water retention. However, it 
is difficult to classify these metabolic fluctuations as a means of osmoregulation 
for several reasons. First of all, not every effect of cell volume change on 
intracellular signalling is related to cell volume regulation. Secondly, different cell 
types will make use of different osmoregulation systems; therefore an 
established mechanism in one tissue must be confirmed in all other types. 
Another difficulty arises due to the multiple mechanisms that cells likely use in 
parallel to regulate cell volume. These systems will often overlap which makes it 
very difficult to analyze the individual effect of intracellular signalling mechanisms 
on osmoregulation (Lang, Busch et al. 1998). Overall, an intracellular mechanism 
serves osmoregulation if it is modified by alterations in cell volume and a 
qualitative/quantitative modification of this intracellular mechanism triggers the 
appropriate alterations of cell volume. For all these reasons, it is difficult to 
characterize the suppression of protein synthesis as a form of osmoregulation 
despite it being an attractive hypothesis. 
The results of this study are extremely novel as this is the first known 
study to examine hyper-osmotic induced cell shrinkage and protein turnover in 
intact skeletal muscle. The most important finding in this study was that exposure 
to hyper-osmotic stress lead to the suppression of protein synthesis and the 
stimulation of protein degradation in intact isolated skeletal muscle. This 
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suggests that cellular shrinkage creates an intracellular catabolic environment, 
but as previously mentioned, the signaling mechanisms which link cell volume 
detection to protein turnover must be established further to verify this. The 
second part of this study aimed to establish some of the signaling mechanisms 
involved. Within protein synthesis, mTOR phosphorylation was found to be 
significantly (p<0.05) increased while p70s6 kinase phosphorylation was found to 
be significantly (p<0.05) decreased. This suggests that p70s6 kinase may be 
involved in the suppression of protein synthesis while mTOR may be primarily 
regulated by nutrient availability. Within protein degradation, calpain autolysis 
was found to be significantly (p<0.05) increased while the ubiquitin proteasome 
system experienced no change. This suggests that calpain activity likely 
contributes to the increase in protein degradation during hyper-osmotic stress 
while the ubiquitin proteasome system may be influenced by mTOR activation. A 
summary of the protein turnover signaling findings in the current study can be 
seen below (see Figure 19). 
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FIGURE 19. Summary of protein turnover data in skeletal muscle during iso-
osmotic and hyper-osmotic stress.  
 
V. Future Directions 
 It is clear that skeletal muscle protein metabolism is altered in response to 
hyper-osmotic stress. However, it is unclear as to whether these perturbations 
are part of a volume regulatory response, or are simply a consequence of the 
changes in cell volume. The current study has begun to establish the signaling 
proteins involved in protein synthesis and degradation pathways during hyper-
osmotic stress, but the bigger picture remains incomplete. In order to help 
determine this, future studies should attempt to elucidate the remainder of the 
signaling proteins involved, particularly upstream. In addition, future research 
should re-investigate the activation of the ubiquitin proteasome system during 
hyper-osmotic stress in skeletal muscle. Using an upstream measurement such 
as mRNA expression of muscle specific E3 ligases (i.e. Atrogin-1 and MuRF-1) 
would allow for an acute determination of its activation during hyper-osmotic 
induced cell shrinkage in skeletal muscle. Lastly, future research should attempt 
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to replicate these findings within an in-vivo skeletal muscle model. Through the 
use of intravenous tracer infusion and muscle biopsy techniques, muscle cell 
volume changes could be achieved and protein metabolism quantified. 
Conducting this research could potentially facilitate new opportunities to 
investigate clinical conditions where decreases in muscle cell volume are an 
issue.  
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APPENDIX I: BREAKDOWN OF MODIFIED SIGMA MEDIA-199 
	  
Components   M4530 
	   	   	   	   	   [1X] 
     AW)-1 
Inorganic Salts 
CaCl2·2H2O    0.265 
Fe(NO3)3·9H2O    0.00072 
MgSO4 (anhyd)   0.9767 
KCl     0.4 
KH2PO4    -- 
Na·Acetate (anhyd)   0.05 
NaHCO3    2.2 
NaCl     6.8  
Na2HPO4 (anhyd)   -- 
NaH2PO4 (anhyd)   0.122 
	  
Amino Acids 
DL-Alanine    0.05 
L-Arginine·HCl   0.07 
DL-Aspartic Acid   0.06 
L-Cysteine·HCl·H20   0.00011 
L-Cystine·2HCl   0.026 
DL-Glutamic Acid   0.1336 
L-Glutamine    0.1 
Glycine    0.05 
L-Histidine·HCl·H2O  0.02188 
Hydroxy-L-Proline   0.01 
DL-Isoleucine   0.04 
DL-Leucine    0.12 
L-Lysine·HCl    0.07 
DL-Methionine   0.03 
DL-Phenylalanine   0.05 
L-Proline    0.04 
DL-Serine    0.05 
DL-Threonine   0.06 
DL-Tryptophan   0.02 
DL-Valine    0.05 
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Vitamins 
Ascorbic Acid·Na   0.000056 
D-Biotin    0.00001 
Calciferol    0.0001 
Choline Chloride   0.0005  
Folic Acid    0.00001 
Menadione (sodium bisulfite) 0.000016 
myo-Inositol    0.00005 
Niacinamide    0.000025 
Nicotinic Acid   0.000025 
p-Amino Benzoic Acid  0.00005 
D-Pantothenic Acid·½Ca  0.00001 
Pyridoxal·HCl   0.000025 
Pydridoxine·HCl   0.000025 
Retinol Acetate   0.00014 
Riboflavin    0.00001 
DL-α-Tocopherol Phosphate·Na 0.00001 
Thiamine·HCl   0.00001 
	  
Other 
Adenine Sulfate   0.01 
Adenosine Triphosphate·2Na 0.001 
Adenosine Monophosphate·Na 0.000238 
Cholesterol    0.0002 
Deoxyribose    0.0005 
Glucose    1.0 
Glutathione (reduced)  0.00005 
Guanine·HCl    0.0003 
HEPES    -- 
Hypoxanthine   0.0003 
Tween 80    0.02 
Ribose    0.0005 
Thymine    0.0003 
Uracil     0.0003 
Xanthine·Na    0.000344 
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APPENDIX II: LABORATORY PROCEDURES 
	  
I. Metabolite Protocol 
 I. Metabolite Extraction 
1) Make up 0.5M PCA solution (21.5mL 70% PCA into 500mL dH2O). 
2) Make up 2.3M KHCO3 (2.3g KHCO3 into 10mL dH2O). Make fresh daily. 
3) Freeze dry tissue (overnight to ensure all water is removed) 
4) Store with dry rite in freezer until powdering 
5) Tease out connective tissue and powder 
6) Place in pre-weighed microcentrifuge tube and weigh (3-5mg) 
7) Place tubes in an ice bucket (make sure tubes remain cold) 
8) Add 600 µL of pre-cooled 0.5 M PCA 
9) Extract for 10 minutes, vortexing several times (ensure all tissue is in contact 
with PCA) 
10) Centrifuge for 10 minutes at 15 000 G (spinning helps remove some of the 
enzymes that can influence concentration) 
11) Remove 540 µL and place in freezer (-20ºC) for 10 min 
12) To the frozen supernatant add 135 µL of 2.3 M KHCO3 and vortex until liquid 
(addition of KHCO3 to a frozen supernatant prevents foaming over) 
13) Centrifuge 10 min 0ºC at 15 000G. Remove supernatant to assay 
metabolites. 
 
 
II. Muscle Adenosine Triphosphate (ATP) and Phosphocreatine (PCr) Assay   
  
            CREATINE KINASE 
P-CREATINE + ADP--------------------------------------- CREATINE + ATP 
                                                           HEXOKINASE 
ATP + GLUCOSE---------------------------------------- ADP + GLUCOSE-6-P 
                  G-6-P-DH 
GLUCOSE-6-P + NADP------------------------------- GLUCANOLACTONE + 
NADPH 
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Reagent STOCK 
CONC. 
FINAL 
CONC. 
VOLUME 
25ML 
VOLUME 
50ML 
VOLUME 
100ML 
1. Tris (on shelf) 
(pH 8.1) 
stored in fridge 
 
1.00 M 
 
 50 mM 
 
 1.25 ml 
 
 2.5 ml 
 
   5.00 ml 
2. MgCl2 (on 
shelf) fresh 
(.2033g/ml)  
1.00 M  1.0 mM  25.00 µL  50.00 µL   100.00 µL 
3. D.T.T.  
(found in -20) 
aliquots -80 
0.5 M  0.5 mM  25.00 µL  50.00 µL   100.00 µL 
4. Glucose  
(on shelf) 
aliquots    ( -80) 
100.0 
mM 
 
100.0 
µM 
 
 25.00 µL  50.00 µL   100.00 µL 
5. NADP  
(found in -20) 
aliquots    ( -80) 
50.0 mM  50.0 µM  25.00 µL  50.00 µL   100.00 µL 
6. G-6-P-DH 
(found in fridge) 
Sigma (G-5760) 
2660 
U/ml 
0.02 
U/ml 
 1.00 µL 
 
 2.00 µL 
 
  4.00 µL 
 
7. ADP (found  
in -20) 
Sigma (A-2754) 
Solid     
8. Creatine 
Kinase 
(found in -20) 
Sigma (C-3755) 
 
324 U/mg 
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Note: Mix reagents 1-5 together. Bring to volume with distilled water and adjust 
to pH 8.1. Then add reagent 6. Mix by inversion with enzymes.  
 
Preparation of Dilute Enzyme 
For step 2. Mix 2.5 µL of Hexokinase with 1ml of buffer. Mix by inversion. 
For step 3. Mix ~1.5 mg of phosphocreatine kinase and 5 mg of ADP into 5 ml of 
buffer.  Mix by inversion. 
Procedure for Assay (Note: Run everything in triplicate) 
 
Part 1.  
1) Fill three wells with a blank (10.00 µL dH2O per well) 
2) a. Vortex each concentration mixture before pipetting 
b. Fill the next five wells with 10.00µL of varying concentrations of ATP      
standard (0.05 mM, 0.1 mM, 0.2 mM, 0.3 mM, 0.4 mM) 
3) a. Vortex each concentration mixture before pipetting  
b. Fill the next five wells with 10.00 µL of varying concentrations of the  
PCr standard.  (0.1 mM, 0.2 mM, 0.4 mM, 0.8 mM, 1.2 mM) 
4) a. Vortex each sample before pipetting  
b. Add 10.00 µL of sample to the appropriately wells 
5) Add 185 µL of buffer to each well 
6) Incubate for 25 minutes.  
7) Read the plate at sensitivity of 80 (excitation setting 340, emission setting 
460) (base line reading) 
 
Part 2.  
1) Add 6 µL of dilute Hexokinase to all of the wells  
2) Place in the dark for 80 minutes 
3) Read the plate (excitation setting 340, emission setting 460) 
     (R2-R1= reflects ATP in extract) 
Part 3.  
1) Add 6 µL of dilute Creatine Kinase to all of the wells 
2) Place in the dark for 120 minutes 
3) Read the plate (excitation setting 340, emission setting 460) 
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       (R3-R2= reflects PCr in extract) 
 
 
ATP (Sigma A-7699) Standard Curve  
make fresh 5.51 mg into 5 ml dH2O  
 
Conc (mM) Stock (µL) dH2O (µL) 
0.05 25 975 
0.1 50 950 
0.2 100 900 
0.3 150 850 
0.4 200 800 
 
 
Phosphocreatine (Sigma P-7936) Standard Curve 
Stored in 7.6 mM aliquots in the -80ºC  
To make 7.6 mM stock: FW (no water) 255.1 mg phosphocreatine into 50 ml 
dH2O 
 
Conc (mM) Stock (µL) dH2O (µL) 
0. 076 10 990 
0.152 20 980 
0.304 40 960 
0.608 80 920 
0.912 120 880 
 
C4H8N3O5PNa  4.4 mol H2Omol-1 substance 
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Therefore its effective weight is 334.3 gmol-1 
 
 
 
II. Tyrosine Assay  
1) Make up 0.1% nitroso-napthol solution (20 mg 1-nitroso-2-naphthol into 
20mL methanol). Mix thoroughly. 
2) Make up 2.5% sodium nitrite solution (25mg sodium nitrite into 1mL of 
water). Vortex. 
3) Make up 1:5 nitric acid solution (5mL nitric acid into 25mL water). Mix 
thoroughly. 
4) Combine 24.5mL nitric acid solution with 0.5mL of sodium nitrite solution. 
Mix thoroughly. 
5) Add 1 mL of nitroso-naphthol solution and 1mL of nitric acid-sodium nitrite 
solution to all samples.  Mix thoroughly.  
6) Place samples in water bath of 65°C for 30 minutes. Allow samples to cool 
post-bath. 
7) After cooling, add 10mL of ethylene dichloride to each sample. Shake 
samples. 
8) Centrifuge samples 2000rpm at 4°C for 10 min. 
9) Transfer aqueous supernatant layer of samples to a well-plate in triplicate 
for fluorometric reading. 
10) Open KC4. Set conditions as: 
-­‐ End-point 
-­‐ Fluorescence 
-­‐ Read samples from both top and bottom 
-­‐ Activation: 485 Emission: 590     
-­‐ Sensitivity: 35 from bottom. 44 from top  
11) Create a standard curve. Run fluorescence readings against the curve for 
tyrosine concentrations. 
III. Protein Synthesis Protocol 
1) Prepare 0.61mol/L trichloroacetic acid solution (4.983g trichloroacetic acid 
into 50mL of dH2O). 
2) Prepare 1mol/L NaOH solution (1.999g NaOH into 50mL of dH2O). 
3) During 75 minute incubation add 0.5mmol/L of L-[14C]-U-phenylalanine 
(9.25MBq/L) into incubation baths with media (1.5µL phenylalanine/15mL 
incubation media). 
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4) After 75 minute incubation, remove muscle from incubation bath, blot dry 
and freeze in liquid nitrogen. Weigh each muscle and record.  
5) Add 100µl of trichloroacetic acid solution to chilled glass homogenizer. 
Additionally, add 10µl of trichloroacetic acid solution for every 1mg of 
muscle. Homogenize thoroughly on ice.  
6) Following homogenization, centrifuge homogenates 10,000rpm 4°C for 10 
minutes. 
7) Use trichloroacetic acid solution to wash the resulting pellet 3 times (100µl 
each time) to eliminate non-bound radioactivity. Store supernatant for 
future analysis. 
8) Re-suspend pellet in 500µL of 1 mol/L NaOH and shake until solubilised. 
9) Load 400µl of solubilised sample and 7.6mL of ScintiSafe solution into 
scintillation tube and load into scintillation counter. Count for 14C. 
10) Load 400µl of sample supernatant and 7.6mL of ScintiSafe solution into 
scintillation tube and load into scintillation counter. Count for 14C. 
11) Calculate protein synthesis by dividing the values incorporated in muscle 
by the non-incorporated values found in the supernatant. Multiply result by 
0.5mmol/L to obtain µmol of phenylalanine incorporated/mg muscle 
tissue/75 minutes. 
 
IV. Western Blotting 
  
I. Sample Preparation 
 
1) Make up homogenizing buffer (250mM sucrose, 100mM KCl, 10mM 
EGTA, 250mL H2O). Fix pH to 6.8 and store in fridge at 4°C. 
2) Remove 10mL of homogenization buffer and add 1 tablet of protease 
inhibitor (#11836170001, Roche, Laval, QC) and phosphatase inhibitor 
(#04906837001, Roche, Laval, QC). 
3) Weigh muscle and prepare glass homogenizers with an appropriate 
amount of homogenization buffer based on the table below: 
Muscle Weights Homogenization 
Buffer Added 
50mg  700ul 
60mg 850ul 
70mg 1000ul 
80mg 1150ul 
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4) Place the glass homogenizer in ice and homogenize muscle tissue 
thoroughly. 
5) Once completed, collect homogenate in an eppendorf tube and store at -
80°C. 
 
 
II. Protein Determination 
 
1) Remove BSA standard (1g/mL) from -20°C freezer and thaw. 
2) Make up standards based on table below: 
 
  
Final Protein 
Concentration (mM) 
Volume of BSA 
(µL) 
Volume of dH2O (µL) 
0 0 1000 
0.05 100 from '0.5' 900 
0.125 500 from '0.25' 500 
0.25 500 from '0.5' 500 
0.5 500 from '1' 500 
1 1000 0 
 
90mg 1300ul 
100mg 1450ul 
110mg 1600ul 
120mg 1750ul 
130mg 1900ul 
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3) Pipette 10µl of each standard concentration in triplicate in a clear 
microtitre plate. Similarly, pipette all samples in triplicate as 1µl and 9µl 
H2O. 
4) Add 200µl of diluted 1:4 Bio-Rad Protein Assay Dye Reagent (#5000006, 
BioRad, Mississauga, ON) to all wells and let incubate for 5 min. Remove 
all air bubbles. 
5) Open KC4 software. Read absorbance at 595nm. Intensity: 3, Duration: 5 
6) In Excel, run a polynomial curve with the blank subtracted from all wells. 
Use the curve equation to determine the y-intercept and multiply by 10 to 
determine the protein concentration of each sample. 
 
 
 
 
III. SDS PAGE 
 
1) To prepare samples for loading, follow table below: 
 
Total Volume (TV) 
 
  
Sample Volume (SV) 
[Protein]
Protein] Final [DesiredT=SV V  
Sample (Laemelli) Buffer (SB) )SB5x for  
5
TV (i.e. 
][ ii
f SB
TVSB =  
Water (H2O) 
 
dH2O = TV − SV − SB  
**Desired final protein concentration is 1µg/µl** 
 
2) Boil samples for 5 minutes and subsequently place on ice for 5 min. 
3) Clean all glass plates with methanol and place in glass holding apparatus 
with small plate facing inward. Ensure glass plates are flush before 
inserting the apparatus into the gel casting stand. 
4) To prepare gels, follow chart below:  
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Percent Gel dH2O (mL) 
Protogel (mL) 
(30% acrylamide) 
Gel Buffer (mL) 
 
  4 (Stacking Gel) 6.1 1.3 2.5 stacking 
      
      
  7.5 (Running 
Gel) 
4.85 2.5 2.5 resolving 
  10 4.01 3.33 2.5 resolving 
  12 3.33 4.01 2.5 resolving 
 
5) Before pouring running gel, add 100µl of Ammonium Persulfate (APS) 
(60mg/600µl) and 10µl of Tetramethylethylenediamine (TEMED). Swirl 
and pour until reaching the depth of the combs. Remove any bubbles with 
methanol and let gel harden.  
6) Once running gel has hardened, pour off methanol. Before pouring 
stacking gel, add 100µl of APS and 20µl TEMED. Swirl and pour to the top 
of small glass plate and place comb in. Once hardened, remove comb and 
rinse wells with dH2O. 
7) Place gel cassettes into electrode assembly with the short plates facing 
inwards, clamp down firmly and place into mini-tank. 
8) Prepare running buffer (250mM Tris Base, 1.92M glycine, 1% SDS, 1L 
dH2O, pH to 8.3. Take 50mL of stock solution running buffer and add 
450mL dH2O). Fill inner chamber with running buffer and add 
approximately 250mL to outside chamber. 
9) Load 5µl of molecular weight standard (#161-0375, BioRad, Mississauga, 
ON) into one well of each gel and an appropriate amount of sample into 
each well of the gel (for protein specific information, see Protein Specific 
Western Blotting Information Table). 
10) Run electrophoresis specific to the protein of interest (for protein specific 
information, see Protein Specific Western Blotting Information Table) 
 
IV. Transfer 
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1) Prepare fresh transfer buffer (312.5mM Tris Base, 2.4M glycine, 100mL 
dH2O; Take 80mL of solution, add 200mL methanol and 720mL dH2O). 
2) Equilibrate sponge pads, fibre pads and filter paper in transfer buffer in a 
plastic tray for 10 minutes. For PVDF membrane, pre-soak in methanol for 
10 seconds, then equilibrate in transfer buffer. For nitrocellulose 
membrane, pre-soak in dH2O for 10 seconds, then equilibrate in transfer 
buffer. 
3) Remove gels from glass plates, discard stacking gel and equilibrate gel in 
transfer buffer for approximately 2 minutes.  
4) Create transfer sandwiches: clear side of transfer cassette, sponge pad, 
fibre pad, 2 filter paper, membrane (PVDF or nitrocellulose), gel, 2 filter 
paper, fibre pad, sponge pad, black side of transfer cassette. Roll out any 
air bubbles in sandwich.   
5) Fill tank with transfer buffer and place tank in an ice bath. Add stir bar into 
the tank to help dissipate heat. Place cassettes into transfer case with the 
black side of the cassette to the black side of the case. Set voltage and 
transfer time according to protein of interest (for protein specific 
information, see Protein Specific Western Blotting Information Table). 
 
V. Antibodies 
 
1) Discard filter papers and gel. Transfer membranes to petri dish. Block 
membranes with milk-TBST solution (20mM tris base, 137mM NaCl, and 
0.1% (v/v) tween 20, pH 7.5) solution.  % of milk and blocking time 
dependent on protein of interest (for protein specific information, see 
Protein Specific Western Blotting Information Table). 
2) After appropriate amount of time discard blocking solution and add 1° 
antibody solution to membrane in the appropriate dilution overnight (for 
protein specific information, see Protein Specific Western Blotting 
Information Table). 
3) After overnight incubation, discard 1° antibody solution and wash the 
membrane 4 times for 5 minutes each time in TBST solution.  
4) After 4 washes, add 2° antibody solution to the membrane in the 
appropriate dilution. Let rock at room temperature. 2° antibody, solution, 
dilution, and time all dependent on protein of interest (for protein specific 
information, see Protein Specific Western Blotting Information Table). 
 
VI. Enhanced Chemi-Luminescence 
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1) After appropriate amount of time discard the 2° antibody solution and 
wash the membrane again 4 times for 5 minutes each time in TBST 
solution. 
2) After 4 washes, combine 1mL each of Chemi-Luminescent HRP Substrate 
Peroxide Solution and Luminal Reagent (#WBKLS0500, Billerica, MA) 
with the membrane and pipette over for 5 minutes. 
3) Blot membrane dry and place between two transparency sheets. Roll out 
any air bubbles.  
4) Expose the membrane using the FluroChem imaging system (Alpha-
Innotec, Santa Clara, CA), and quantify using the AlphaEaseFC Software 
(Alpha-Innotec, Santa Clara, CA). Exposure time dependent on protein of 
interest (for protein specific information, see Protein Specific Western 
Blotting Information Table). Determine the density of the bands using 
“Image J” software (National Institutes of Health, Bethesda, MD).  
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Protein Specific Western Blotting Information 
 
 
 
 
mTOR 
 
Phosph
o-mTOR 
p70s6k Phospho-
p70s6k 
Ubiquitin 
Conjugates 
Actin µ Calpain 
 
Protein 
Load 
 
 
15µl 
 
15µl 
 
10µl 
 
10µl 
 
12µl 
 
12µl 
 
10µl 
Stacking 
Gel 
 
4% 4% 4% 4% 4% 4% 4% 
Running 
Gel 
 
7.5% 7.5% 10% 10% 7.5% 7.5% 7.5% 
 
Gel 
Electroph
oresis 
 
 
 
2 hours 
at 120V 
 
2 hours 
at 120V 
 
90 min at 
120V 
 
90 min at 
120V 
 
75 min at 
100V 
 
75 min at 
100V 
15 min at 
100V 
followed 
by 60 min 
at 160V 
Membrane 
 
PVDF PVDF PVDF PVDF PVDF PVDF Nitro-
cellulose 
 
Transfer 
 
2 hours 
at 100V 
2 hours 
at 100V 
90 min at 
100V 
90 min at 
100V 
75 min at 
100V 
75 min at 
100V 
90 min at 
100V 
 
Blocking 
 
 
1% milk-
TBST for 
2 hours 
1% milk-
TBST for 
2 hours 
2.5% milk-
TBST for 1 
hour 
2.5% milk-
TBST for 1 
hour 
5% milk-
TBST for 1 
hour 
5% milk-
TBST for 1 
hour 
5% milk-
TBST for 1 
hour 
 
 
1° 
 
 
 
1:1000 
rabbit 
polyclona
lin 
1%milk-
TBST 
1:1000 
rabbit 
monoclo
nalin 1% 
milk-
TBST 
1:1000 
rabbit 
polyclonal 
in 5% 
milk-TBST 
1:1000 
goat 
monoclon
al in 5% 
milk-TBST 
1:2000 rabbit 
polyclonal in 
5% milk-
TBST 
1:5000 
mouse 
monoclon
al in 5% 
milk-TBST 
1:1000 
rabbit 
monoclon
al in 1% 
BSA-
PBST 
 
2° 
 
 
 
 
 
 
1:7000 in 
1% milk-
TBST 
anti-
rabbit for 
2 hours 
1:7000 in 
1% milk-
TBST 
anti-
rabbit for 
2 hours 
1:6000 
anti-rabbit 
in 5% 
BSA-
TBST for 1 
hour  
1:6000 
anti-goat 
in 5% 
BSA-
TBST for 1 
hour 
1:6000 anti-
rabbit in 5% 
milk-TBST 
for 1 hour 
1:5000 
anti-
mouse in 
5% milk-
TBST for 1 
hour 
1:5000 
anti-rabbit 
in 5% 
milk-TBST 
for 1 hour 
Exposure 
 
 
 
2 min 2 min 2 min 2 min 2 min 2 min Cut 
membrane 
at 43kDa. 
30 min 
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V. Western Blotting Images 
1) Total mTOR        
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2) Phospho-mTOR 
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3) Total p70s6 kinase 
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4) Phospho-p70s6 kinase 
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5) Ubiquitin Conjugates and Actin  
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6) µ-Calpain  
 
 
 
 
 
 
